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Abstract
RNA splicing has enabled a dramatic increase in species complexity. Splicing occurs in over 95% of mam-
malian genes allowing the development of exceptional cellular diversity without an increase in raw gene
numbers. This is highlighted by the fact that human and nematodes have the same number of genes (20,000
human genes versus 19,000 genes in Caenorhabditis elegans). Although the mechanistic process of splicing is
now well understood there remains a multitude of unexplored dynamics that have only become visible with
the power of next generation sequencing (NGS).
The human brain is one of the best examples of an intricate cellular structure. Neuronal cell types
are incredibly diverse and specialised, regulated through various transcriptional mechanisms. Recently,
long genes (150kb+) have been implicated as crucial to neuronal function and their impairment has been
attributed to several neurological disorders. I explore this relationship further by showing that long genes are
more highly expressed in the brain than other tissues. Long genes are also distinct in that they are deficient
in H3k36me3, a histone mark largely associated with splicing and active transcription. Through analysis of
brain RNA-seq data, a novel splicing mechanism known as recursive splicing was identified in long introns.
Recursive splice sites (RSS) consist of an intronic 3’splice site followed immediately by a 5’ splice site. These
sites result in a zero-length exon that regulates the use of cryptic promoters ensuring only the functional
isoform is expressed. This discovery lead me to question if other non-canonical forms of splicing are common
in the brain.
Backsplicing is a recently discovered splicing mechanism pervasive in the tree of life. This occurs
when a 3’ end of a downstream exon is spliced onto the 5’ end of an upstream exon resulting in a circular
RNA molecule (hereafter: circRNA). circRNA are enriched in neuronal genes and mediated by RNA binding
factors. I have identified and quantified the presence of circRNA within the brain, identifying a large number
of highly expressed novel circRNA. From these findings I identify a subset of highly expressed backsplice
junctions that occur between two proximal genes from the same family.
vii
In order to understand the function of these splicing reactions I inspected the splicing features
themselves, namely; the 5’ and 3’ splice sites and the branchpoint. The branchpoint remains a poorly char-
acterised feature and until recently very few have been experimentally validated. I explore these features
through the ExAC and UCLex consortia, using cumulative variant ratios to annotate invariant positions
within the branchpoint and splice sites. By identifying invariant positions I could then investigate how vari-
ation impacts splicing efficiency by integrating whole exome and RNA sequence data from the GEUVADIS
consortium. Findings show that exon expression is a poor indicator of splicing dysfunction, showing a three
fold lower sensitivity than direct analysis of splice junction reads. I also devise a variant effect score that
captures a significant portion of change in splice site efficiency enabling improved prediction of deleterious
variants.
Together, this thesis hints at the massive potential of NGS to investigate the diversity of splicing
related features while identifying novel features that could be implicated in neurological dysfunction.
viii
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Chapter 1
Introduction
1.1 Next generation sequencing enables high throughput, nucleotide
resolution analysis of cellular processes
Next generation sequencing (hereafter: NGS) has catapulted biological sciences forward by making genome-
wide studies possible. The power and versatility of genome-wide sequence cannot be underestimated, massive
volumes of NGS data are now freely available to analyse and explore.
There have been major advances over the previous high throughput, hybridization-based microar-
ray technology. NGS provides better quality data, more robust results and lower noise [Buermans and den
Dunnen, 2014]. This technology has been applied in large consortia for the systematic evaluation of hu-
man polymorphism such as the landmark 1,000 genomes project [Abecasis et al., 2012], the UK10K exome
project [Walter et al., 2015] and most recently the staggering 65,000 sample Exome Aggregation Consortium
(ExAC) [The EXaC Consortium, 2015]. Recent projects have also aimed at combining DNA information
with additional data, in particular RNA-sequencing (hereafter: RNA-seq). These include the GEUVADIS
project [Lappalainen et al., 2013], Illumina Bodymap (www.illumina.com; ArrayExpress ID: E-MTAB-513)
and Genotype-Tissue Expression Consortium (GTEx) [Genotype-Tissue Expression Consortium, 2015].
Next generation sequencing continues to rapidly accelerate our ability to characterise and discover
novel cellular processes. NCBI’s public short read sequence archive now hosts over 1,000 TB of data, the
equivalent of resequencing the human genome with a 1,000,000 times coverage (Figure 1.1).
It is crucial to find effective ways of analysing these large datasets, particularly given their relevance
in understanding cellular biology and ultimately disease etiology. This thesis develops methods by leveraging
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Figure 1.1: Growth of data in NCBI Short Sequence Read Archive (SRA) as a function of time. [NCBI]
publicly available data to explore the non-coding elements of the human brain far more powerfully than was
possible before. Primarily, this thesis aims at exploring non-canonical aspects of gene expression, particularly
related to RNA splicing.
Compared to microarray technology where a control sample is required to normalize background hy-
bridization [Wang et al., 2009], next generation sequencing can provide absolute expression values. Although
there remains known bias in the form of batch effects [Taub et al., 2010; SEQC/MAQC-III Consortium,
2014], especially due to the rapid improvement in equipment and laboratory kits, these samples still provide
sequence information which is valuable in its own right.
1.2 Splicing in vertebrate genomes
Splicing was first discovered over thirty years ago in adenovirus and highlighted the alternative use of exons
to create multiple mRNA from a single gene locus [Chow et al., 1977; Berget et al., 1977]. With the aid
of sequencing we now know that splicing plays a integral role in mRNA diversity affecting over 95% of
mammalian genes and controlling regulatory processes such as chromatin modification [Pan et al., 2008;
Barash et al., 2010]. This is an essential aspect of the increase in complexity of vertebrates as they share
similar gene numbers to invertebrates (20,000 human genes versus 19,000 genes in Caenorhabditis elegans).
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Figure 1.2: Graphical representation of the splicing process. In brief; after binding of splicing factors of
snRNPs the splice sites flanking the intron and branchpoint, several rearrangements occur resulting in the
transesterification of the severed 5’ intron end to the adensoine at the branchpoint creating an intronic lariat.
Following this the transesterification of the 5’ exon end and the 3’ exon start create the final mRNA and
release the intronic lariat. [Kornblihtt et al., 2013]
This process is mediated by the spliceosome, a complex of ribonuclearprotein that assembles flank-
ing introns through identification of consensus sequences known as splice sites (the upstream 5’ site and
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downstream 3’ site) and the branchpoint. U1 small nuclear riboprotein (snRNP) binds to the 5’ splice site
with U2AF35 and U2AF65 binding to the 3’ splice site and proximal polypyramidine tract respectively. The
upstream branchpoint is bound by the branchpoint-binding protein (BBP). Hereafter, the severed 5’ intron
end is covalently bonded through transesterification of the adensoine at the branchpoint creating an intronic
lariat. The second step is the transesterification of the 5’ exon end and the 3’ exon start thereby creating
the final mRNA and releasing the intronic lariat (Figure 1.2 outlines this process).
The sequence composition of the splice site plays a crucial role in the efficiency of splicing and
the inclusion/exclusion of exons. Thus splice sites tend to be highly conserved. Splice sites that diverge
from this consensus provide additional variation and these exons may be skipped without the addition of
several other modifiers such as cis-regulatory sequences (exonic enhancers/silencers) and trans-acting factors
(tissue-specific RNA binding factors such as PTB and NOVA [Ule et al., 2006; Jelen et al., 2007; Kafasla
et al., 2012]).
The splicing process has been shown to occur simultaneously during transcription [Beyer and Osheim,
1988; Khodor et al., 2011]. Recently, overwhelming evidence has pointed to the co-transcriptional splicing of
the majority of exons while still associated with chromatin [Tilgner et al., 2012]. This is further highlighted
by the study of co-transcriptional splicing in the human brain and its use to estimate speed of transcription
and provide key insights into exonic definition [Ameur et al., 2011]. An example of co-transcriptional splicing
is shown in Figure 1.3, the iconic saw-tooth pattern indicates where splicing occurs and the gradient can be
used to infer transcriptional speed.
1.2.1 Circular RNAs are a novel class of non coding RNA created by backsplic-
ing
Circular RNA (hereafter circRNA) are pervasively expressed in mammalian cells and enriched in brain, blood
and exosomes [Ashwal-Fluss et al., 2014; Rybak-Wolf et al., 2015; You et al., 2015; Venø et al., 2015]. These
non-coding RNA are formed through structural changes within their intronic flanks, often catalysed by RNA
binding proteins and palindromic repeat sequences. circRNA can be identified by a back-splice junction
which is not present in canonical linear isoforms.
Synthesis of circRNA is reliant on intronic sequences
Advances in the field have confirmed the mechanism that allows the 3’ end of a downstream exon to be spliced
onto the 5’ end of an upstream exon, known as a ’backsplice’ (see Figure 1.4). Biogenesis is mediated by
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Figure 1.3: (A) Co-transcriptional splicing pattern in human brain in the genes AUTS2 (A. top) and C21orf34
(A. bottom). A clear sawtooth pattern is visible when looking at the histogram of read coverage across
introns. (B. top) Diagram showing the formation of pre-mRNA creating the ’sawtooth’ pattern across
introns. (B. bottom) Extrapolation of the expected pattern to model intronic read coverage. [Ameur et al.,
2011]
the spliceosome. circRNAs are generated co-transcriptionally, their production rate closely related to their
flanking introns. Canonical mRNA compete with circularization in a tissue-specific manner conserved in
vertebrates. This introduces a potential function for circRNAs as regulators of gene expression by competing
with linear transcripts. [Ashwal-Fluss et al., 2014]
Figure 1.4: Diagrams depicting formation of circular RNA via canonical or internal transcription compared
to linear mRNA formation [Salzman et al., 2012]. Canonical and circle splicing are mutually exclusive and
are in direct competition.
5
1.3 Analysis of RNA-seq data and evaluation of splice junctions
This study implements tools and pipelines to exploit an underutilized aspect of RNA sequencing, the splice
junctions. A splice junction is inferred from those sequence fragments that overlap exon-exon boundaries
in the mRNA and hence map to different exons on the genome (Figure 1.5). This is an incredibly powerful
tool to estimate splicing efficiency, provide nucleotide resolution on splicing reactions and reveal patterns
not readily evident from gene or exon expression.
1.3.1 Alignment of NGS fragments
Alignment of read fragments produced by NGS technology to the genome/transcriptome is the first step
in processing human sequencing data. This can be achieved with a number of different algorithms. The
alignment of millions of read fragments requires heuristic approaches for accurate mapping in reasonable
wall clock time. This is achieved by sacrificing sensitivity, generally a maximum of 2 mismatches is allowed.
Recent advances have improved the level of permutation permitted but this generally results in performance
loss. BWA [Li and Durbin, 2009] and BOWTIE [Langmead et al., 2009] both apply the burrows wheeler
compression transform to enable fast searching of read space. There is now a second generation of aligners
commonly used such as BOWTIE2 [Langmead and Salzberg, 2012].
1.3.2 RNA-seq analysis software
The analysis of RNA-seq data remains highly dependent on different applications of the technology to
organism and features of interest. There are multiple methods and approaches to take into consideration.
One strategy is the mapping of the sequence fragments to the genome, recovering splice junctions using
either predefined exon-exon scaffold reads (such as Tophat2 [Trapnell et al., 2009; Kim et al., 2013]) and/or
independent alignment of subsequences (such as GSNAP [Wu and Nacu, 2010], HISAT [Kim et al., 2015],
STAR [Dobin et al., 2013]). A second method is direct alignment to the transcriptome and quantification
of transcript values through assignment of read counts to isoforms (such as RSEM [Li and Dewey, 2011],
Kallisto [Bray et al., 2015]). In this study the focus is on genomic alignment enabling identification of novel
features.
There are several common software for quantification of isoforms, a typical example is Cuﬄinks
[Trapnell et al., 2010a, 2012]. Although this does not directly measure splicing change it does enable the
building of novel isoforms from the splice junction information. The general steps involve assembling tran-
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Figure 1.5: Illustration showing how splice junction reads (red) are mapped to two distinct genomic positions
based on their constitutive exons (orange). This provides direct evidence of splicing in the cell. [Wikimedia
Commons, 2009].
scripts based on splicing information, comparison and merging with known annotations and finally differential
expression based on the enhanced annotations.
Splice junction reads are essential to accurate splicing analysis
Splice junction reads are under-utilized as a means to identify and quantify splicing changes. The mixture-
of-isoforms (MISO) model [Katz et al., 2010] is probably the most notable exception to this. MISO was the
first, popular tool to investigate splice junctions between alternate exons. Figure 1.6 shows the basic outline
of the software. It calculates the levels of inclusion of alternate exons using the ’percent spliced in’ (PSI)
statistic. This is calculated based on the ratio between splice junctions that support its inclusion compared
to those that connect the constitutive exons. In order to determine differential splicing a Bayes factor is
applied which quantifies the odds of differential exon usage in two sample groups. Posterior probability
distributions of PSI are calculated and used to estimate the Bayes factor.
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MISO remains one of the most robust tools, one of the few to look at single skipping events rather
than complete isoform expression. However, it is not designed to handle low frequency cryptic events as it
requires input of all exons to be tested. The inclusion of cryptic events generally requires enough read depth
to build an exon structure.
Figure 1.6: MISO work-flow (A) Work-flow showing read fragments from sequencing to alignment and
quantification. Fragments aligning to constitutive exons are marked in black and grey, alternative exons
in white (B) Psi estimate uses alternate exon reads and splice junctions. (C) Using paired end reads
greatly improves results by allowing for insert size to be used (shown in orange) along with the insert
distribution (D) A graph showing the estimated psi parameter based on single/paired-end reads based on
read coverage. These results were generated by re-sampling at different depths with standard deviations
included. Ultimately, paired-end reads have an appreciable effect on expression variance. [Katz et al., 2010]
More recently tools such as Junction-seq have been designed to examine splicing efficiency in a
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similar method to exon differential expression requiring two groups to test [Love et al., 2014; Hartley and
Mullikin, 2015]. In the following studies, the non-canonical nature of the splicing required the creation of
custom algorithms and often required detailed analysis of raw alignment data.
1.4 Sequencing datasets utilized in this thesis
1.4.1 Primary datasets
Two primary datasets are used for multiple analyses in this study (Table 1.1). Each will be discussed below
in detail.
Consortium Project Application Detail Number of Samples
UKBEC Consortium total RNA-seq Human brain 48
UCLex Exome Multiple studies 3,500
Table 1.1: Primary next generation sequencing data analysed in this study.
UKBEC RNA-seq Brain data
Brain samples were collected from the Medical Research Council Sudden Death Brain and Tissue Bank
(Edinburgh, UK). Post-mortem human tissue from four individuals of European descent confirmed to be
neurologically normal during life. Twelve central nervous system regions were sampled from each individual.
The regions studied were: cerebellar cortex, frontal cortex, temporal cortex, occipital cortex, hippocam-
pus, the inferior olivary nucleus (sub-dissected from the medulla), putamen, substantia nigra, thalamus,
hypothalamus, intralobular white matter and cervical spinal cord. The libraries were sequenced using Illu-
minas HiSeq2000 with 100 base pair paired-end reads. Sample data can be found in the Appendix Table
1.
UCLex Exome consortium
UCLex is an in-house consortium of custom capture and whole exome sequencing data. It consists of over
3,500 exomes. These are a collection of rare, mendelian type disease and common disease groups with
the addition of healthy controls. As the data are in-house this provides a unique opportunity to explore
variation across samples and the ability to inspect individual variants within sample groups. The power
of a consortium such as this is the standardised processing and variant calling. This allows for improved
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filtering of spurious variation and an estimate of variant frequency in various disease conditions. Details on
the distribution of samples between groups can be found in Table 1.2.
Phenotype #Samples
Inflammatory Bowel Disease 799
Huntington’s Disease 48
Ophthalmology, Retinal disorders 371
Dermatology, Inflammatory disorders 63
Sudden Cardiac Death 98
Keratoconus 12
Primary Immunodeficiency 128
Prion Disease 1112
Epilsepsy 164
ARVC 28
Bone Marrow Failure 184
Cone Rod Dystrophy 40
Healthy Controls 892
Table 1.2: UCLex Sample Information. Phenotype and number of samples
1.4.2 Public datasets analysed
Each thesis chapter makes extensive use of public data to expand on hypotheses and reinforce findings. Table
1.3 shows the data consortia analysed and applied in this study. Each dataset will be introduced briefly.
Consortium Project Application Detail Number of Samples
GTEx Consortium polyA+ RNA-seq Multiple human tissues 1,749
Illumina Bodymap total RNA-seq Multiple human tissues 48
ENCODE CHIPseq Histone mark,human and mouse brain 12
ExAC Consortium Exome Multiple studies 61,000
GEUVADIS project Exome, polyA+ RNA-seq Multiple studies 426
Table 1.3: Public next generation sequencing consortia data analysed in this study.
ENCODE
The Encyclopedia Of DNA Elements (ENCODE) was launched in September 2003 to identify functional ele-
ments throughout the human genome. The landmark project aimed at using high-throughput approaches on
a variety of functional elements. ENCODE targets range from genes, promoters, enhancers, to transcription
factor binding sites, methylation sites and histone modifications. For the purpose of this study I will only
focus on a subset of these data, specifically histone modification data taken from mouse and human brain.
[The ENCODE Project Consortium, 2004]
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ExAC Consortium
Exome Aggregation Consortium (ExAC) is an initiative from a collaboration of groups centred around the
Broad Institute and Massachusetts Institute of Technology. The goal is to aggregate vast collections of
whole exome data and provide general statistics to the scientific community. The dataset currently spans a
staggering 61,000 unrelated individuals. [Samocha et al., 2014; The EXaC Consortium, 2015]
GTEx Consortium
Genotype-Tissue Expression (GTEx) project provides a large resource for interpreting tissue-based gene
expression, regulation and its relationship to variation. This project aims to study gene expression differences
between multiple human tissue types and compare this to genotype information. This information has been
used to calculate expression based quantitative trait loci (eQTL) and provide a large, publicly available
dataset for further scientific investigation. This consortium contains over 237 post-mortem donors, with 28
tissue samples per donor spanning 54 distinct body sites. Paired-end mRNA sequencing was performed on
a total of 1749 samples, with an average of 82 million reads per sample. This information was processed
into files freely downloadable from their website (http://www.gtexportal.org/home/). [The Genotype-Tissue
Expression (GTEx) project Consortium, 2015]
Illumina Bodymap
The Illumina Bodymap is a resource of 16 human tissues made available from Illumina sequencing. A total
of 48 samples (including biological replicates) were sequenced using a ribosomal RNA depletion protocol to
produce paired-end sequenced data (www.illumina.com; ArrayExpress ID: E-MTAB-513).
GEUVADIS project
The GEUVADIS consortium combined RNA-seq from lymphoblastoid cell lines of 465 individuals with
variant data from the 1,000 Genomes Project. A subset of 423 samples were analysed as these were part
of the 1,000 Genomes Phase 1 dataset. Paired-end, 75bp RNA-seq was performed on total RNA of the 465
EpsteinBarr-virus-transformed lymphoblastoid cell lines. This resulted in an average of 48.9M reads per
sample. [Abecasis et al., 2012; Lappalainen et al., 2013]
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1.5 Overview of chapters
A brief overview of chapters in this thesis is outlined below.
1.5.1 Long genes, recursive splicing and their relationship to the brain
Lately, several studies have indicated that long genes are linked to several neurological disorders [Lagier-
Tourenne et al., 2012; Polymenidou et al., 2011; King et al., 2013]. I investigate the characteristic differences
in these long genes by noting their enrichment in brain and distinct epigenetic profile (compared to shorter
genes). It is noted that in Drosophila melanogaster long introns can contain cryptic elements known as
recursive splice sites (hereafter: RSS) that allow for processing of large introns. Recursive splicing is the
reconstitution of a 5’ splice site after an initial splicing reaction, hence resulting in no exonic inclusion. In this
chapter RSS are identified for the first time in long genes within the human brain using a custom designed
pipeline. The proposed function of these recursive elements is the maintenance of canonical upstream exons.
Alternate cryptic promoters result in inclusion of a ’poison’ exon that marks the transcript for nonsense-
mediated decay (NMD).
1.5.2 Circular RNA are a pervasive phenomena linked to neuronal genes
The circularization of exons is far more pervasive than first believed. Circular RNAs (hereafter: circRNA) are
not only enriched in neuronal genes but their synthesis appears to be partially regulated through RNA binding
proteins [Rybak-Wolf et al., 2015; You et al., 2015; Venø et al., 2015; Ashwal-Fluss et al., 2014]. Current
research also suggests that circularization partially regulates transcription by reducing the production of
canonical mRNA. Here I develop a pipeline to mine a large brain cohort for circular RNA, produce high
confidence counts and explore the circRNA landscape in brain. From these findings I identify a subset of
highly expressed back-splice junctions that occur between two proximal genes from the same family. In order
to explore the presence or absence of these junctions a custom alignment algorithm was implemented.
1.5.3 Exploring polymorphic variation using large exome consortia
Large exome consortia provide a unique opportunity to use variant information in ways never before possible.
For instance, it is possible to identify important genes due to significant deficiency in deleterious variation.
This relationship has been extrapolated in this study to identify positions within features that are highly
invariant. A pipeline was developed to create a nucleotide resolution map of splice sites and branchpoints
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based on exome data. This identified specific positions in splice sites and branchpoint motifs that show fewer
mutations.
In order to explore the effects of this variation a pipeline was created to integrate splicing vari-
ants with gene expression data. Gene/exon expression did not provide significant resolution between vari-
ant/wildtype groups highlighting the need for more sensitive measures. Multiple statistics were applied using
splice junctions which provided far better resolution of functional change. This change in splicing efficiency
can be partially captured through a sequence-based variant effect score.
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Chapter 2
Recursive splicing in human brain
2.1 Introduction
Work from this thesis chapter has been published in [Sibley et al., 2015].
2.1.1 Long genes form a subclass with unique characteristics
The human transcriptome contains a great diversity of genes, one of the striking aspects is their length.
Gene lengths range from the Tyrosine tRNA ( 0.2kb) to the Dystrophin gene (2500kb). Over 2,000 genes
in the human genome are longer than 150kb, more than ten times the average gene length (10-15kb). This
raises questions as to the diverse roles these genes could play and what unique mechanisms are required for
correct transcription of this extreme subclass.
In this chapter I will focus on the characteristics of long genes and their relevance to clinical pathol-
ogy, particularly neurological, and the discovery of cryptic elements known as recursive splice sites.
Long genes as candidates for neurological pathology
Recent literature suggests that disruption of long genes (150kb+) are a key component of several neurological
disorders. Long genes differ from shorter genes in transcript processing and key RNA binding proteins. Both
TDP-43 and FUS/TLS (Fused in sarcoma/translated in lipsarcoma) are elongation factors enriched in large
introns [Polymenidou et al., 2011; Lagier-Tourenne et al., 2012]. Their absence reduces expression of these
genes substantially by affecting transcript stability of intronic sequences. Similarly, Topoisomerase 1 (TOP1),
a protein that resolves DNA super-coiling, decreases expression of long genes in a dose-dependant fashion in
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neurons of both mouse and human [King et al., 2013].
Disruption of the MECP2 gene, involved in methylation and transcriptional repression has been
shown to cause Rett syndrome, an autism-like disorder with severe neurological implications [Chahrour and
Zoghbi, 2007]. This genes methylation function is widespread but long genes are particularly susceptible
due to their increased length and hence the effect of this gene is largely present in brain and neurons [Gabel
et al., 2015].
Recently, recurrent DNA double-strand breaks (RDCs) that occur in primary neural stem progenitor
cells (NSPCs) have been found within long genes. Almost 90% of these genes are involved in synapse function
and/or neural cell adhesion indicating length may play an important role in this process which is essential
for neural development. [Wei et al., 2016a]
These findings suggest that long genes are intimately linked to neurological dysfunction. Further in-
vestigation into the processing of long genes is essential to improve our understanding of splicing mechanisms
within these genes.
Long introns as a peculiar feature of long genes
A common characteristic of long genes is that they often contain one or more long introns. Long introns are
generally defined as those longer than 50kb. Over 3,000 human introns are larger than 50 kb, with nearly
half being longer than 100 kb [Belshaw and Bensasson, 2006]. Long introns place a high resource burden on
the cell and raise several questions regarding their presence in higher eukaryotes. Firstly, the transcription
of large introns requires a massive energy commitment to produce pre-mRNA that will be removed and
degraded. Secondly, this increases time of transcription for creation of the mRNA (a 150kb intron takes
nearly 20min to transcribe!). Thirdly, large introns increase the likelihood of inclusion of cryptic splice sites
either through translocation, mutation or RNA binding protein dysfunction [Belshaw and Bensasson, 2006].
These were initially defined as pseudo-exons or cryptic exons [Sun and Chasin, 2000]. One source of cryptic
exons are repeat elements which are surprisingly common in higher eukaryotes.
Repeat elements are abundant in long introns and play a role in their processing
One central question to the transcription and correct splicing of long introns is how splice sites can be
efficiently connected across such a huge distance. In vertebrate genomes introns are significantly enriched
for interspersed repetitive elements (mainly SINEs and LINEs). Figure 2.1 shows the presence of repeat
elements across various species. These repeats have enough complementarity to form stems in large introns,
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effectively folding the intron into compact structures [Shepard et al., 2009]. Similar RNA hairpins are crucial
for splicing of group I and group II introns present in bacteria [Pyle et al., 2007]. These hairpins found in
eukaryotes have also been shown to regulate alternative splicing [Rogic et al., 2008]. In human an average
of 9.4 possible hairpins were found per 50kb of intron, these mostly formed between oppositely oriented
primate-specific Alu-repeats (81.7%) [Belshaw and Bensasson, 2006]. An interesting exception to this case
is chicken, where LINE elements replace this functionality [Belshaw and Bensasson, 2006]. In conclusion,
these RNA hairpins enable the folding of intronic RNA and would significantly reduce the distance between
donor and acceptor splice sites making them central to the correct processing of large introns.
Figure 2.1: The percentage of different interspersed repeats for the complete set of large introns for various
species. The light grey bars are for the total percentage of repeats in large introns. The dark grey bars are
for the short interspersed element repeats. The black bars are only for long interspersed element repeats.
[Belshaw and Bensasson, 2006]
Repeat elements can form cryptic elements if not repressed
An interesting side effect of long vertebrate introns containing many Alu repeats is that their splice sites
need to be masked by RNA-binding proteins (RBPs). hnRNP C is an example of an RBP that represses
Alu elements [Zarnack et al., 2013]. The uncontrolled expression and splicing of these elements could lead
to disease and as such much be tightly regulated by the cell [Dhir and Buratti, 2010]. The evolution of a
repeat element as it gets included in a transcript is highlighted in Figure 2.2.
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Figure 2.2: Schematic showing exonisation of Au elements and its evolution to non-sense element (NE) and
finally to pseudoexon (PE) potentially conveying a novel function often resulting in human disease. [Dhir
and Buratti, 2010]
The evolution of Alu exons into cryptic elements indicate the need to carefully explore introns
for similar features. Potentially long introns may harbour some of these elements, potential remnants of
evolution that may fulfil important functions.
2.1.2 Cryptic elements in long genes
Recursive splicing is a novel mechanism observed in vertebrates to process long introns
Interestingly, invertebrate genomes that contain long introns are almost completely deficient of repeat ele-
ments hence stem/hairpin structures are practically absent [Belshaw and Bensasson, 2006]. Hence, another
mechanism must be operating to process these long introns. In Drosophila it was discovered that large in-
trons undergo a process called recursive splicing (Figure 2.3) to remove an intron by processing it in multiple
steps [Hatton et al., 1998; Burnette et al., 2005].
Recursive splicing was first discovered in Drosophila melanogaster’s Ultrabithorax (Ubx) gene as a
mechanism to process its long intron [Hatton et al., 1998]. The 73kb Ubx intron was spliced out in four steps,
the final step including a recursive site. Recursive sites consist of back-to-back 3’ and 5’ intronic splice sites
thereby creating a zero-length exon. Computational analyses have predicted nearly 200 recursive sites in D.
melanogaster, 7 of which were validated by inhibiting lariat de-branching enzymes [Burnette et al., 2005].
A recent breakthrough (and co-publication of [Sibley et al., 2015]) identified nearly 200 recursive sites on a
genome-wide scale in Drosophila by leveraging RNA-seq data using splice junctions and co transcriptional
splicing patterns [Ameur et al., 2011; Duff et al., 2014].
Given the enrichment of recursive splicing in long genes [Duff et al., 2014] and the established
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relationship between long genes and neuronal tissue [Polymenidou et al., 2011; Lagier-Tourenne et al., 2012],
I endeavoured to explore the existence of recursive sites in the long genes (150kb+) within human brain.
Figure 2.3: Schematic of the recursive site creating a zero length exon in fruit fly needed to process long
introns . [Sibley et al., 2015]
2.1.3 Histone modifications are a central characteristic of genes and their cell
specific expression
Another crucial aspect of genes is their chromatin state. This is largely determined by histones which are
composed of highly conserved proteins (H3, H4, H2A, H2B and H1). These function as building blocks,
packaging DNA into nucleosomes that can be folded into chromatin super structures [Luger and Richmond,
1998]. Histones can be posttranslationally modified, most commonly on their tails. The N and C terminals
protrude from the core nucleosome and have the potential to be modified and to interact with neighbouring
nucleosomes. This can function as binding sites for other proteins and regulate chromatin structure. Histone
modifications include acetylation, phosphorylation, methylation, and ubiquitylation.
Histones have been identified as integral components of the machinery that modulates gene tran-
scription, repair, replication and recombination [Strahl and Allis, 2000]. A list of histone marks associated
with transcription are shown in Figure 2.4. One of the most well known and well defined histone modifications
related to transcription is the trimethylation of H3 lysine 36 (H3k36me3).
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Figure 2.4: Histone modifications known at different residues within the N terminus of histones, some of
these have been associated to transcription. [Strahl and Allis, 2000]
H3k36me3 histone modification provides insight into transcription
H3k36me3 is widely recognised as a transcriptional histone mark. It has been linked to active gene bodies,
splicing, repair and gene activation [Jenuwein and Allis, 2001; Kolasinska-Zwierz et al., 2009; Sims and
Reinberg, 2009]. H3k36me3 is enriched around exons, although alternatively spliced exons tend to show
lower levels, indicating a link with transcription and splicing [Sims and Reinberg, 2009]. Transcription
can also accumulate further histone marks creating a feedback effect. This may also explain why levels of
H3k36me3 also tend to increase toward the 3’ end of the gene [Pokholok et al., 2005].
Interestingly, although there are multiple writers of H3K36 methylation only SETD2 is responsible
for H3K36 trimethylation. Not surprisingly, SETD2 has been identified as instrumental in dealing with
cancer’s aberrant transcription [Pfister et al., 2015]. H3k36me3 deacetylation is necessary after transcription
to prevent initiation of transcription from aberrant sites within the gene [Pokholok et al., 2005].
Duff et al. in their analysis of recursive sites in fruit fly did not identify any histone marks enriched
for recursive sites in Drosophila, however they did not evaluate whether intron length had any impact on
histone enrichment [Duff et al., 2014]. The further investigation of H3k36me3 is another key characteristic
that can help understand processing differences between long and short genes.
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2.2 Methods
2.2.1 Software and tools used in this Chapter
Several software packages were used extensively in this thesis. Python [Cock et al., 2009] (programming
language) was used for general file parsing, scripts to wrap and automate other tools and custom analysis on
BAM/SAM alignment files. Python packages include Pysam, Biopython and Bedtools libraries [Cock et al.,
2009; Quinlan and Hall, 2010; Li et al., 2009].
R statistical [R Core Team, 2016] was applied for normalisation of gene expression (DESeq, DE-
Seq2 [Anders and Huber, 2010]), general matrix manipulation (dplyr,tidyr) and plotting of data (ggplot2)
[Wickham, 2009; Wickham and Francois, 2015; Wickham, 2016]).
Bedtools [Quinlan and Hall, 2010] was used for manipulating genomic coordinate data. This tool is
without a doubt the most essential to any bioinformaticians kit.
2.2.2 Ancillary public datasets
Both public and primary data were used in this study. The UKBEC Brain consortium was used as primary
data. Public RNA-seq datasets used in this study include; GTEx consortium [The Genotype-Tissue Expres-
sion (GTEx) project Consortium, 2014] and Illumina Bodymap version 2.0 [Derrien et al., 2012]. Please see
Table 1.3 for more information.
Additional datasets analysed for this study alone include C2C12 mouse myoblasts (GSM521256)
and myogenic lineage (GSM521259) [Trapnell et al., 2010b] , mouse embryonic stem cells (GSM1346027)
and motor neurons (GSM1346035) [Herrera et al., 2014], and differentiation of haematopoietic stem cells
(GSM992931) into erythroid lineage (GSM992934) [Madzo et al., 2014].
2.2.3 Expression of long genes in the brain
I quantified the relationship between expression of long genes in neurons and all major tissue types available
in the GTEx consortium [Genotype-Tissue Expression Consortium, 2015], Illumina Bodymap version 2.0
(www.illumina.com; ArrayExpress ID: E-MTAB-513) and several mouse cell lines during differentiation
(details in Datasets section). For GTEx, gene count data were downloaded, normalised and fold change
ratios where calculated using DESeq [Anders and Huber, 2010]. The ratios were correlated to gene length
to determine trends in the data.
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For the Illumina Bodymap (www.illumina.com; ArrayExpress ID: E-MTAB-513) and ancillary mouse
datasets; raw sequence data were downloaded, mapped to their respective genome assemblies (hg19 for
human and mm9 for mouse) using Tophat2 [Trapnell et al., 2009]. Aligned reads were summarised into gene
counts using HTSeqCount [Anders et al., 2015] and differential expression between relevant groups done with
DESeq[Anders and Huber, 2010].
Plots were created using the log fold change calculated by DESeq and length of the longest transcript
for each gene. Loess smoothing curves were calculated and graphing was done using ggplot2 [Wickham, 2009].
2.2.4 Identification of recursive splicing in brain
An in-house bioinformatics pipeline was created to process the UKBEC Brain consortium sequence data
(Figure 2.5). Raw FASTQ data were aligned to the human genome (build hg19) using the STAR aligner
(v2.3 [Dobin et al., 2013]) with enhanced splicing annotations from GENCODE v19 [Steijger et al., 2013].
All aligned BAM files were pooled and only reads within long introns (150kb+, n=943 in 780 genes) were
selected. An algorithm then scanned for split reads (also referred to as junction reads) that mapped to a
canonical exon and terminated intronically. Junctions were classified as known or novel using the knowngene
UCSC annotations [Abe et al., 2015].
These detected junctions were then enumerated and paired if they spanned the intron in an exon-like
fashion with a maximum of 400bp gap between the junctions (see PE1 and PE2 from Figure 2.5). For these
potential exons, all stop codons in all frames were identified.
Furthermore, all junctions from the 5’ end of the upstream exon were identified and classified based
on their presence in UCSC, RefSeq and GENCODE databases [Harrow et al., 2012; Abe et al., 2015; O’Leary
et al., 2016], all novel junctions were noted as potential cryptic upstream elements.
Another method to identify recursive sites is using the co transcriptional ”saw-tooth” pattern created
by pre-mrna transcripts mapping to the intron [Ameur et al., 2011]. For more information please refer
to Section 1.2. Pooled BAM files were summarised into 5kb bins and these were used to perform linear
regression. As transcription occurs at a constant rate, similar gradients should be seen across all introns
within a genes. Dividing the large intron based on the above identified splice junctions I could determine
whether the new gradients would resemble other introns within the gene (Figure 2.6).
Similarly, an alternate dataset was generated using cross-linking and immunoprecipitation (iCLIP)
for fused in sarcoma (FUS) in human brain. iCLIP analysis of FUS binding enables linear regression analysis
in a similar way to total RNA-seq data and results in a saw-tooth patten.
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Final classification as a recursive splicing element, required adequate splice junction coverage, the
significant improvement of co-transcriptional gradient with addition of the splice junction in both RNA-seq
and FUS iCLIP datasets.
H3k36me3 histone enrichment in long genes
In order to determine whether long introns have unique histone enrichment patterns compared to short
introns, data from both mouse (mm9) and human (hg19) brain was downloaded for H3k36me3 and a control
enhancer mark, H3k4me1 (ENCODE project data) [Parkhomchuk et al., 2009]. For mouse, embryonic brain
tissue was used (accessions: GSM1000072, GSM1000096) and for human ; Cingulate Gyrus, Hippocampus
(Middle) and Mid Frontal Lobe from adult (accessions: GSM669947,GSM773013,GSM773052).
For each dataset, reads were binned into 100bp windows, normalised by total read count. Each
exon was flanked by 400bp to compensate for exonic histone signal extending into the intron. Introns were
adjusted accordingly. All bins overlapping exons were summed and a mean value was taken across introns.
All introns were binned according to size in the following categories: 400nt-2kb, 2-5kb, 5-20kb, 20-50kb,
50-100kb, 100+kb. Only transcripts with at least one intron of 50kb+ were selected.
All introns and exons were normalised using the shortest intron bin (400bp-5kb). RPKM (Reads
Per Kilobase of transcript per Million mapped reads) values were then calculated for both exons and introns
based on their normalised values. Pearson correlation is then calculated between normalised intron counts
and intron length. For exons the normalised exon RPM was correlated to the shortest neighbouring intron.
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Figure 2.5: Recursive splicing pipeline. Briefly, data are aligned to the human genome, BAM alignment files
are parsed for splice junction information which is used to annotate any recursive-like junctions that exist
within large introns. If a potential recursive junction is found the co transcriptional pattern of the intron
with or without the proposed recursive site is checked.
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Figure 2.6: The impact of inclusion of the recursive site to modelling the co-transcriptional sawtooth pattern
present in RSS genes. Through use of splice junction data, effectively dividing the intron into two. This
results in significantly improved goodness of fit of the linear model. [Sibley et al., 2015]
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2.3 Results
2.3.1 Expression of long genes is enriched in the brain
It has already been observed in ES cells that long genes, which are mostly silent in an undifferentiated
state, become expressed in neurons [Thakurela et al., 2013]. Long genes (150kb+) appear to be consistently
more highly expressed in brain in both GTEx (Figure 2.7) and Illumina Bodymap datasets (Figure 2.8).
The Illumina Bodymap data includes both Dystrophin and Titin, well known long genes that are highly
expressed in muscle. These tend to follow the expected trend, however, Dystrophin’s longest intron is only
45kb, this could explain its slightly higher expression pattern.
Figure 2.7: GTEx data comparisons by tissue show that long genes are more highly expressed in brain
compared to other tissues. Dotted blue line indicates 150kb gene length. Plot shows gene length (log10) as
a function of ratio of expression in tissue / expression in brain. Data are represented as Loess smoothing
curves. Trendlines indicate an overall enrichment of expression of long genes in the brain compared to all
other measured tissues.
For further investigation several other public datasets were explored. Figure 2.9 shows the increase
in expression of long genes during differentiation of mouse embryonic stem cells into motor neurons compared
to myogenic and erythroid differentiation.
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Figure 2.8: Multiple plots from Illumina Bodymap II resource. Graphs show gene expression in each tissue
relative to brain (log2foldchange). Genes containing recursive sites (red) and two long genes highly expressed
in muscle tissue (dystrophin and titin) are highlighted. All remaining genes are in grey.[Sibley et al., 2015]
Figure 2.9: Public data showing effects of differentiation on different cell lines (after versus before) as
a log fold change. Samples analysed from left to right include; C2C12 mouse myoblasts (GSM521256)
into myogenic lineage (GSM521259) [Trapnell et al., 2010b] , mouse embryonic stem cells (GSM1346027)
into motor neurons (GSM1346035) [Herrera et al., 2014], and differentiation of haematopoietic stem cells
(GSM992931) into erythroid lineage (GSM992934) [Madzo et al., 2014]. [Sibley et al., 2015]
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2.3.2 Recursive splice sites identified in human brain
Figure 2.10 highlights the filtering process from 1.5 billion reads, to the 3,000 novel junctions and finally to
the 11 confirmed recursive sites in 9 genes (see Table 2.1). Part of the filtering process was modelling the
co-transcriptional splicing pattern and determining if the inclusion of the RSS improved regression gradient.
This could be done in both RNA-seq and FUS iCLIP data and clearly shows the consistent use of the
recursive sites in these genes (Figure 2.11).
Figure 2.10: Filtering of read junctions through the recursive pipeline. Pooling all brain samples 1.5 billion
reads is reduced to 2981 splice junctions within long introns to the final 11 recursive sites found in 9 genes.
Recursive sites showed a strong consensus 3’ intronic splice site immediately followed by a 5’ splice
site (Figure 2.14) comparable to those found in Drosophilia [Hatton et al., 1998]. These sites are highly
conserved across all vertebrate species (Figure 2.13). Interestingly, these 9 genes (see Table 2.1) are also
some of the longest in human and these elements appear to originate from some of the longest introns across
species (see Figure 2.12 A). From looking at the distribution of novel recursive junctions it is clear that the
vast majority occur in long genes (Figure 2.12 B).
Alternative 5’ splice sites were identified downstream of the recursive site indicating the potential
for inclusion of an alternate exon (hereafter: recursive exon, Figure 2.15). The alternative splice sites also
appear to be conserved (Figure 2.15 c). These exons contained a stop codon in almost every frame, indicating
that these are likely poison exons which would cause transcript degradation through the nonsense-mediated
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Figure 2.11: Ratio of improvement in gradient before/after adding the recursive site to modelling of the co-
transcriptional sawtooth pattern. Red and black dots show junctions that significantly improve the regression
gradient and goodness of fit. Grey dots show no significant change. Red dots contact RS-sites and black
dots contact sequence of 3’ splice sites. [Sibley et al., 2015]
Figure 2.12: (A) Intronic lengths of RSS introns compared to all introns across different species. (B)
Histogram of gene lengths (grey bars) with percentage of genes with RSS containing novel junctions (blue
bars). [Sibley et al., 2015]
decay pathway. This also reinforces previous studies that found exon recognition is essential for splicing
to occur [Ameur et al., 2011]. The recursive exon appears to be a requirement for correct identification
of the splice site, as experimentally proved in CADM1 [Sibley et al., 2015]. Interestingly, as compared to
Drosophilia, the recursive site does not appear to be necessary for effective splicing of the intron.
The inclusion of a recursive exon, although at very low levels, does occur in all cells. This was
investigated by interrogating the upstream gene body of 142 candidate recursive sites (high confidence
targets, all cassette exons starting with 5’ splice motif GURAG, and novel junctions detected that were
consistent with recursive sites but failed to meet significance in linear regression analysis). Several junctions
were found between recursive sites and cryptic upstream elements including unannotated promoters and
exons. RT-PCR confirmed that an alternative promoter in NTM leads to 100% inclusion of the recursive
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Figure 2.13: (Top) Recursive sites as detected using junction reads (black), the upstream splice junction
(red) is abundant while the downstream poison exon junction (blue) is far less prevalent. (Middle) Linear
regression of the sawtooth pattern created by binning read coverage across the intron clearly showing splicing
to the recursive site. (Bottom) The sequence of the recursive site, showing 3’ splice site (blue) head-to-head
with a 5’ splice site (red). These sites have a high level of species conservation, particularly across mammalian
species.
Figure 2.14: Motif of the recursive site showing the polypyramidine tract and 3’ splice site followed imme-
diately by a strong consensus 5’ splice site.
exon. A similar minor promoter was discovered in CADM2 (Figure 2.17). Figure 2.16 shows the major (P1)
and minor (P2) promoters and the associated splice site strength (calculated by MaxEnt [Yeo and Burge,
2004]) for both the reconstituted recursive and alternative RS-exon 5’ splice site. Each promoter donates
three nucleotides from its upstream exon to reconstitute the RS 5’ splice site and this has a large impact
on splice site strength. The major promoter reconstitutes a stronger splice site and is preferentially selected
by the splicing machinery. However, the minor promoter’s reconstituted RSS is weaker than the alternative
RS-exon 5’ splice site and therefore the RS-exon site is preferentially selected. All MaxEnt scores show a
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Figure 2.15: (A) Representation of recursive poison exons containing multiple stop codons (red bars) and
consensus splice site locations (blue bars). (B) Phylo-P conservation scores aligned at RS-sites and (C)
alternate recursive exon 5 splice sites. [Sibley et al., 2015]
similar trend for all RS sites and are present in Table 2.2.
2.3.3 H3k36me3 signal is deficient in long introns
The strong sequence motif of RSS lead to further questions regarding the intronic characteristics of long
genes. Such strong conservation may be necessary to distinguish these sites from other background cryptic
elements if the environment was not conducive to transcription. I investigated the relationship between
intron length and H3k36me3, a well known transcription and splicing-related histone mark. Sequence data
from human post-mortem brain tissue and mouse brain tissue were downloaded from ENCODE. H3k36me3
was compared against H3k4me1 (an unrelated enhancer mark) to determine if the effect was specific.
Based on the mouse embryonic brain data (Figure 2.18) a significant decrease in splicing mark
H3k36me3 was seen with increase in intron length. This pattern was not seen in the control enhancer
mark, H3k4me1. Similarly, exon enrichment for H3k36me3 was inversely proportional to intron length but
remained constant in H3k4me1. This systematic decrease in enrichment is clearly visible when looking across
the introns grouped in bins according to length (Figure 2.19).
The samples analysed for the human data are shown in Figure 2.20. These data follow the same
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Figure 2.16: MaxEnt scores [Sibley et al., 2015]
trend as dictated by the mouse data but does not have a strongly significant correlation. Reasons for this
could include the quality of DNA as human post-mortem tissue tends to be more degraded and hence more
variable.
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Figure 2.17: Sawtooth co-transcriptional pattern showing the improvements made by linear regression (blue
lines). Primers were included in the first RS exon (blue) and second RS exon (red). Zoomed area shows the
sequence at the start of the second RS-exon which is also linked to a minor promoter. [Sibley et al., 2015]
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Gene, RS site Sequence reconstituted 5’ss Score RS-exon sequence Score RS-site favoured?
PDE4D RS-site 1 TGGGTAAGT 9.23 TGGGTAAGT 9.23 YES
CADM1 CAGGTAAGT 12.75 GCAGTAAGT 7.27 YES
ANK3 AAGGTAAGT 12.19 AGGGTAAGT 10 YES
OPCML CAGGTAAGT 12.75 GAGGTATGA 7.98 YES
PDE4D RS-site 2 TGGGTAAGT 9.23 GAGGTATGG 7.93 YES
CADM2 RS-site 1 AAGGTGAGT 11.31 TGGGTAAGT 9.23 YES
ROBO2 CATGTAAGT 8.03 ACTGTATGA 3.19 YES
HS6ST3 CAGGTAAGA 11.11 ATAGTATGT 4.33 YES
NCAM1 CAGGTAAGA 11.11 TATGTATGG 1.39 YES
CADM2 RS-site 2 AAGGTAAGC 10.62 AAGGTAAAA 7 YES
NTM AAGGTAAGT 12.19 CAGGTAGGT 10.73 YES
Table 2.2: MaxEnt splice scores for both RSS reconstituted 5’ss and the RS-exon alternative 5’ ss.
Figure 2.18: Mouse embryonic brain: Relationship of intron length to histone marks H3k36me3 (splicing,
repair and active transcription) and H3k4me1 (enhancer mark). Introns are binned and normalised by length.
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Figure 2.19: Mouse embryonic brain: Relationship of intron length to histone marks H3k36me3 (splicing,
repair and active transcription). Introns are binned and read counts are normalised by length.
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Figure 2.20: Adult human brain: Relationship of intron length to histone mark H3k36me3 (splicing, repair
and active transcription) across multiple brain regions. Enrichment of histone marks in exons and introns
shown on the left and right respectively.
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2.4 Discussion
Long genes have previously been linked to neurological disorders [Lagier-Tourenne et al., 2012; Polymenidou
et al., 2011; King et al., 2013]. Here I strengthen that connection by proving that long genes are enriched
in brain in multiple datasets. Differentiation appears to have an effect on gene length, showing a slight
trend and enrichment in long genes over differentiation. This could be due to the length of time and energy
required for transcribing these genes. In actively dividing cells expression of long genes may be impractical
and unlikely to complete in a timely fashion.
Here I document the first study to identify recursive splicing in vertebrates. Splicing proteins process
these sites in two steps; the recursive exon is detected and the first half of the intron is removed. The recursive
5’ splice site is then recognised and the remainder of the intron is removed without inclusion of any exonic
nucleotides. A custom pipeline was created to analyse post mortem brain data and 11 high confidence
sites were discovered. This pipeline utilised both junction reads and co-transcriptional splicing patterns to
effectively characterise these splicing reactions.
Recursive sites are highly conserved and appear to prevent the use of cryptic upstream elements
not consistent with the main isoform (Figure 2.21). Although fewer sites are reported than in Drosophilia,
the mechanism is also somewhat different, rather than being used to process long introns, recursive sites in
human are involved in promoter control. Exon definition is a key element in splicing, even when processing
recursive sites an alternate 5’ end is required for splicing recognition. This exon contains multiple stop
codons and thus its inclusion in a transcript results in its degradation via nonsense mediated decay (NMD).
The inclusion of the recursive exon depends on the strength of the RSS which is in direct competition
with the alternate, recursive exon 5’ splice site. RSS strength is largely determined by the upstream exon
as this provides three crucial nucleotides of the core splice site motif. This implies that inclusion of a non-
canonical upstream exon could lead to a weak RSS which would be out-competed by the alternate 5’ splice
site of the recursive exon. This could be predicted computationally through the splice site scoring program
MaxEnt. This opens exciting possibilities to explore splicing competition as a mechanism of transcriptional
control.
It is also interesting to note that RSS genes are some of the longest in the human genome. It is
striking that the appearance of Alu type SINE repeat elements have provided a way for higher eukaryotes to
efficiently process long introns without the help of RSS, which is required in Drosophilia. This may indicate
that from this point in evolution RSS were no longer required for intron processing and could differentiate
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into other roles. Alternatively, it is also possible that RSS sites have evolved from Alu elements that evaded
silencing RNA binding proteins.
Further work will include investigation of shorter introns for potential recursive behaviour and
exploration of other non-canonical splicing mechanisms that may operate in long introns. Another avenue
to explore is the evolution of these elements. It is clear that more work can be done on the relationship
between repeats in long introns and the creation and function of recursive elements. The synergy in this
relationship is likely to yield fascinating insights into cellular evolution.
Figure 2.21: (A.) Model for inclusion of recursive exon dependant on promoter usage. (B.) Schematic showing
the mechanism of action for recursive splicing resulting in inclusion of the poison recursive exon with use of
the minor isoform while it is excluded in the major isoform.
An investigation into histone characteristics of long genes shows a deficiency of H3k36me3 in long
introns. This potentially plays a significant role in preventing aberrant transcription of sites within the
intron. It also explains why H3k36me3 deacetylation is essential after transcription to prevent interference
from within the intron [Pokholok et al., 2005].
This also points to the need for an extremely strong splice signal for the recursive site to be effective.
Exploring the relationship between genes with long introns and the constantly growing histone modification
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landscape could yield insights into the relationship between processing and chromatin structure. Specifically
an investigation into sub groups of long introns that have very few repetitive elements or enrichment of
enhancer/silencing marks might pave the way to finding other functionally related elements.
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Chapter 3
Characterising circular RNA in the
human brain
3.1 Introduction
History of RNA circles
Circular RNA (circRNA) are a recent addition to the growing ranks of non-coding RNA. The circularization
of exons within a gene was originally discovered in plants, encoding subviral agents [Sanger et al., 1976] and
later in the sex-determining SRY gene as a result of unusual genomic structure [Capel et al., 1993]. CircRNA
were also identified at the Fmn locus as creating an inert transcript thereby reducing the expression level of
the formin protein [Chao et al., 1998].
Circular RNA are prevalent in all forms of life
Recent publications provided computational and experimental evidence that circRNAs are pervasively ex-
pressed throughout the tree of life [Danan et al., 2012; Salzman et al., 2012; Wang et al., 2014]. From these
findings a subclass of circRNA was identified as microRNA sponges, such as CDR1as. CDR1as acts a super
sponge for mir-7, implicated as an important microRNA in Alzheimers disease. Absence of this circRNA in
zebrafish caused a 70% reduction in mid brain size with complete loss in 5% of animals [Memczak et al.,
2013]. Similarly, the SRY circle was shown to be a mir-sponge for mir-138 [Hansen et al., 2013].
The functions for the majority of circRNA remain unknown. The majority do not exhibit traits or
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capacity to act as miRNA sponges and possess low RNA binding protein density when compared to 3’/5’
UTRs. Several studies have been unable to find evidence of translation of circRNA [Guo et al., 2014; You
et al., 2015; Memczak et al., 2013; Wang et al., 2014] although a recent publication indicates that a rolling
circle amplification mechanism (RCA) can in fact translate circRNA in eukaryotic cells [Abe et al., 2015]
An alternate class of circular RNA, circular intronic RNA (ciRNA), form by circularization of introns.
ciRNA impact expression of their parent genes by effecting elongation of the Pol II complex [Zhang et al.,
2013]. Knock-down of ci-ankrd52 slightly increased intron retention and a knock-down of downstream splicing
events. ciRNA appear to be localized to the nucleus (rather than circRNA which is largely cytoplasmic) and
some appear to have alternate roles (other than regulating their parent gene) as they aggregate at different
locations in the nucleus. The authors argue that ciRNA may bind RNA binding proteins in a similar way
that (after depletion of debranching enzymes) intronic lariats in the cytoplasm sequester TDP-43 thereby
suppressing TDP-43 toxicity in ALS disease model [Armakola et al., 2012; Zhang et al., 2013]
Flanking intronic sequences are repeat based or bind splicing factors
Flanking intronic sequences play a key role in circularization. This can be achieved through two known
mechanisms; reverse complementary repeat sequences or the binding of splice factors. The splicing factor
muscleblind (MBL) has been shown to bind to neighbouring introns drastically increasing the production
rate of its circRNA. The proposed mechanism suggests than when MBL protein is in excess, it binds to
neighbouring introns increasing the circular isoform and decreasing mRNA production. [Ashwal-Fluss et al.,
2014]
Reverse complementary repeats in neighbouring introns allow for pre-mrna folding, creating the
loop required for backsplicing (Figure 3.1). Alternative formation of inverted repeated Alu pairs (IRAlus)
and competition between them can lead to alternative circularization, meaning several different circRNA
can be formed from the same gene (Figure 3.2). On average 3 Alu elements were present in both up- and
downstream introns, indicating even partially complementary Alus are enough to promote RNA pairing.
Any complementary sequences in flanking introns can promote circularization, an example of this is the SRY
gene [Wang et al., 2014; Zhang et al., 2014]
Removal of these sequences dramatically decreases circularization efficiency. Intron length on its
own is not a reliable predictor of circularization. The complementary flanking sequences are not conserved
between human and mouse and indicate the ability for rapid evolutionary change. [Zhang et al., 2014]
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Figure 3.1: Diagrams outlining the proposed mechanism of circularization with inverted repeated Alu pairs
(IRAlus) [Zhang et al., 2014].
Figure 3.2: (A) Due to multiple Alu elements, there are several conformations pre-mrna can fold into
indicating multiple circRNA can be formed from the same gene. (B) Three different tracks using different
RNA-seq protocols namely, PolyA+ (inclusion of only mRNA with polyA tails), PolyA- (inclusion of all
RNA while depleting rRNA) and PolyA- RNase R (polyA- with digestion of all linear RNA with RNase R).
This shows the presence of several circRNA only when depleting linear RNA with RNase R. [Zhang et al.,
2014].
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circRNA are enriched in mammalian brain and neurological development
Several recent studies have shown that circRNAs are significantly enriched in mammalian brain but even
more so in synaptic genes and synaptoneurosomes [Rybak-Wolf et al., 2015; You et al., 2015; Venø et al.,
2015; Ashwal-Fluss et al., 2014]. These circRNAs are often well conserved between human, mouse and
occasionally Drosophila and are regulated during neuronal differentiation and development [Rybak-Wolf
et al., 2015; Venø et al., 2015]. Interestingly, significant expression differences are often observed between
the linear and circular isoforms of neural genes, furthermore, the localization of circRNA products (and not
their linear counterparts) tend to be higher at the synapse than in the cytoplasm [Rybak-Wolf et al., 2015;
You et al., 2015]. This leads to the conclusion that some circRNA may function independently of their linear
siblings.
Brain related RNA binding proteins such as TDP-43, FUS and muscleblind have already been
implicated in neurodegenerative disease and further work is essential to elucidate mechanisms and effects on
circRNA and their relationship to pathology [Lagier-Tourenne et al., 2012; Polymenidou et al., 2011].
circRNA diversity in brain is estimated at 3 circRNA per gene. However, over 2,000 genes show
10 or more isoforms [Rybak-Wolf et al., 2015; Venø et al., 2015]. Their complexity is further increased
as there is evidence of differential inclusion of internal exons [You et al., 2015]. There is also evidence
that circRNA differential expression is linked to neural plasticity [You et al., 2015; Venø et al., 2015]. This
research provides tantalizing clues to the complex cellular processes regulating creation of circRNA and their
potential importance in neuronal function.
Potential use of circRNA as biomarkers and their relevance to cancer genomics
circRNAs have been quantified at detectable levels in saliva, blood and within exosomes. Interestingly, 60%
of the 327 circles identified in saliva are non-canonical [Bahn et al., 2015]. The enrichment of circRNA in
blood is comparable to brain, this provides a unique opportunity to explore their roles as biomarkers [Bahn
et al., 2015]. Some circRNA found in blood appear to be more highly expressed than their linear isoforms
and may provide a proxy for quantification of expression. [Memczak et al., 2015]
The discovery of exosomes, small membrane vesicles secreted by cells, has provided a unique op-
portunity to identify biomarkers for disease. Over a 1,000 circRNAs have been identified in human serum
exosomes and are enriched in exosomes compared to host cells indicating an active regulation of circRNA
transport.[Bahn et al., 2015]
In cancer serum differential regulation of circles is clearly present with 67 missing species and 250
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novel cancer-specific circRNA being detected. [Li et al., 2015] A recent publication has shown that novel
circRNA can be produced from gene fusions caused by chromosomal rearrangements (see Figure 3.3). These
circRNA can contribute to cellular transformation, promote cell viability and confer resistance to thera-
peutics. They have been shown to have tumor-promoting properties in in vivo testing. [Guarnerio et al.,
2016]
Figure 3.3: (A) Chromosomal translocation in cancer produces a gene fusion which results in novel confor-
mations of complementary Alu elements. These elements promote the circularisation of exons within the
fusion gene. (B) The oncogenic fusion proteins (both linear and circular RNA) promote tumourigenesis and
resistance to therapeutics. [Guarnerio et al., 2016]
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3.1.1 Challenges in identifying Circular RNAs
Detection of circRNA relies on the backsplice junction
CircRNA have remained largely unexplored until now due to difficulties with detection as the only distin-
guishing feature from the linear transcript is the unexpected backsplice junction. This has lead to several
strategies in an attempt to identify and quantify circRNA. Initial approaches focused on validation using
custom sequencing kits, mostly exploiting RNase to deplete linear RNA [Jeck et al., 2013; Zhang et al.,
2014]. However, total RNA-seq provides a unique opportunity to explore circRNA without requiring specific
sample preparation.
Two approaches are currently in use; the first splits unmapped reads into smaller fragments, aligns
them to the genome and looks for inverted mapping of read fragments, indicating a potential backsplice
site. This approach can successfully identify novel, non-canonical, circRNA but requires reads to overlap the
backsplice in a more or less symmetrical way [Memczak et al., 2013; Hoffmann et al., 2014]. This greatly
reduces its sensitivity. The majority of new tools embrace this strategy while focusing on different attributes
of circRNA [Zhang et al., 2014; Gao et al., 2015].
Recently, an aligner was created using this strategy [Hoffmann et al., 2014], however the resource
consumption and time usage on a large dataset (50 high depth RNA-seq samples) is intractable. Average
runtime per sample is 15 hours with a memory footprint of 20%. For over a terabyte of data this translates to
a minimum of 200GB of memory. This software appears to be most effective when analysing data produced
by a circRNA enrichment protocol (such as the use of RNase R to degrade linear mRNA) with far lower
depth.
An alternative approach is to create a database of all possible backsplices from annotated exons.
Aligning unmapped reads back to this database can accurately quantify all circles. Although this method
is more sensitive, it is heavily annotation dependent and cannot identify non-canonical circles. [Salzman
et al., 2012; Wang et al., 2014]. All circular RNAs discovered thus far have been uploaded and merged into
a public repository called Circbase [Memczak et al., 2013].
3.2 Methods
In addition to the software and tools described in section 2.1.1, this section lists the methods that have been
specifically used for this chapter.
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3.2.1 Accurate quantification of Circular RNA
Effective identification of circular RNA relies on detection of the backsplice location. Careful quality control
is essential to accurately quantify circles. The outline of the bioinformatics pipeline developed for this
purpose is shown in Figure 3.4.
Identifying all circRNA in human brain using total RNA sequencing data
All brain samples were mapped to the human genome (build hg19) using the STAR aligner (v2.3 [Dobin
et al., 2013]). All unmapped reads were pooled and realigned using the strategy outlined in [Memczak et al.,
2013], all reads were divided into smaller seed fragments, aligned to the genome and all inverted fragments
were taken as proof of circularization (see Figure 3.4 A). These were then enumerated and filtered to produce
a list of potential circular rna. All identified circRNA were merged with all known circRNAs in the Circbase
repository.
Creation of a backsplice database and enumeration of circRNA
A backsplice database was created from the discovered circRNA (see Figure 3.4 B); the 5’ and 3’ ends of each
circRNA are joined to create an artificial reference with a total length of 150 nucleotides. This required a
100bp read to overlap with at least 15 nucleotides. Sequence reads from each brain sample were then aligned
against the circRNA database and human genome simultaneously using Bowtie2 [Langmead and Salzberg,
2012].
3.2.2 Pitfalls to identification of Circular RNA
One concern when investigating circRNA is to be aware of situations in which reads align to scaffold junctions
that do not originate from circular molecules. Although a strategy for paired-end sequencing will be discussed
in the following section it is also important to investigate the spurious alignments than can occur across the
read scaffold. Figure 3.5 shows various instances were reads can be misaligned to scaffolds.
The first clear concern is mismatches across the read indicating mismapping. Collections of mis-
matches on a single end, centred around the central splice location or randomly distributed were common
(Figure 3.5 A,B,C). These alignments often were primary and may have resulted from similar pseudo genes,
other non-canonical splicing or PCR artefacts.
A second consideration is imbalance in the overhang lengths. The scaffolds were created to minimize
this as each end was 15bp shorter than a read fragment. This however, did not circumvent minimum overhang
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Figure 3.4: Outline of bioinformatics pipeline for processing raw sequence reads to produce high confidence
count data for both novel and known circRNA. Briefly, all samples were aligned using STAR, (A) unmapped
reads were pooled and initial circRNA discovery was done based on the algorithm from Memzack et. al
[Memczak et al., 2013]. (B) All identified circRNA were merged with known circles from Circbase and ap-
propriate backsplice scaffolds were generated for each circRNA. All samples were realigned to the human
genome (GRCh37) and backsplice scaffolds. (C) Raw alignment results were filtered using read scaffold align-
ment. Paired-end information was used to determine which fragments originated from a circular molecule
(green, blue read) and which did not (purple read). (D) This information was used to determine differences in
distributions of alignment scores for true positives (green line) and false positives (purple line). A threshold
could then be assigned to filter reads of interest, this produced a final list of high confidence counts.
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reads, with multiple mismatches on the overhang (Figure 3.5 D). More common than this was the aligner
labelling the last bases as low quality (a known bias in Illumina reads is their quality drop off at the 3’
terminus) thereby soft-clipping these bases without directly affecting alignment score.
Figure 3.5: Graphical display of several common misalignments that occur when mapping reads to scaffold
backsplice junctions. Separate exon ends are shown in orange and green, mismatches are shown in red, low
quality bases shown in purple.
It is clear strict filters need to be applied to minimise the occurrence of these false positive alignments.
Several filters were implemented to remedy these effects and are described below.
Quality control of backsplice hits, filtering and library normalisation
All samples were pooled to maximize power for the remaining experiments. Each read pair was evaluated
based on the alignment score of the read mapping to the backsplice database (hereafter: backsplice/scaffold
read) and the location of its mate which aligned to the human genome (hereafter: genome read) (see Figure
3.4 C).
All genome reads falling outside the predicted bounds of the backsplice read (denoting the outer
boundary of the circRNA) are considered false positives. The backsplice reads alignment score is recorded
and the distribution of true positives and false positives is calculated (Figure 3.4 D). These distributions
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allowed determination an appropriate alignment score cut off of -15 (Figure 3.6).
Lastly, the mapping quality (MAPQ) for each backsplice read was required to be higher than 20.
Mapping quality grades the uniqueness of the read i.e. the confidence the read aligner has that it has mapped
the read to the correct location.
Figure 3.6: Distribution of alignment scores for backsplice reads. Separate categories were created for genome
reads located within the backsplice read bounds (”inside”, red), false positives were those located outside
the backsplice boundary (”outside”,green) and those with unmapped mate pairs (”unmapped”,blue). A
threshold was set to a minimum alignment score of -15 (scale from -60 to 0) to minimise the inclusion of
false positive results.
Finally, the raw counts for all circRNAs are library normalised using the bioconductor DESeq package
[Anders and Huber, 2010]. A further step is taken to normalise these circRNA by comparing junction counts
of backsplices to brain housekeeping gene GAPDH. High confidence circRNA are then annotated accordingly
based on overlapping genes, pseudogenes, including a list of recently identified constrained genes intolerant
to non-synonymous mutation [Samocha et al., 2014]. This is compiled into a database of circles, hereafter:
CircBrDB.
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Case study: circRNA differential expression in Bipolar disorder
After the creation of the CircBrDB circRNA catalogue in healthy human brain, these backsplices could
be searched for in other datasets. One example is a study done by Akula et. al [Akula et al., 2014] on
4 post-mortem samples of dorsolateral prefrontal cortex from 4 bipolar patients and 4 controls. Data was
downloaded from the repository (GEO: GSE53239) , aligned to the database of scaffold backsplices and the
human genome (GRCh37). These raw alignment results were then filtered as stipulated in section 3.2.2. The
resulting backsplice counts were imported into DESeq [Anders and Huber, 2010], library normalised and low
abundance counts were removed. The remaining data were run through the differential expression software
to determine fold change across control and bipolar brains. Results were ranked by P value.
3.2.3 Pairwise analysis of highly similar gene pairs
A subgroup of the most highly expressed backsplice junctions were found to connect two proximal genes
rather than lie within a single gene. These genes were often from the same family, with clear homology and
similar structure. An example of this is the tubulin protein family i.e. TUBA1A - TUBA1B and TUBB2B
- TUBB2A. These backsplices have been detected in other datasets [Rybak-Wolf et al., 2015; Guo et al.,
2014] and were disregarded as alignment artefact. In order to explore this relationship further a pipeline
was developed to determine if these backsplice junctions and associated trans-splicing junctions were in fact
biological in nature.
A flow diagram covering the computational steps of the pipeline is shown in Figure 3.7. This was
implemented using Python, Biopython and custom Python libraries.
Compiling annotations
The CircBrDB backsplice junctions were annotated using GENCODE [Harrow et al., 2012] v19 exon and
intron annotations. All information was stored in data structures to allow for ease of access.
Parsing aligned data to retrieve valid alignment pairs for further analysis
Previously aligned data from all 48 brain samples generated by Bowtie 2 was sorted by read name and anal-
ysed. For each read pair, the read aligning to the backsplice scaffold in CircBrDB database was interrogated
to ensure it was of high mapping quality. This was done to correct for the heuristic nature of the Bowtie2
algorithm, which does not penalise certain low quality mismatches towards the end of the read fragment.
Manual analysis was required in order to ensure read integrity. For each read pair, the read mapping to the
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backsplice scaffold (backsplice read) and its mate (mate read) were investigated. Each read must achieve a
mapping quality score (MAPQ) above 25 or complete sequence match to either the genome reference or the
backsplice sequence (see Figure 3.7A).
Creating paired gene annotations for proximal gene pairs
A paired annotation is created for all provided gene pairs using GENCODE transcript annotations. This
involves identifying reciprocal exons between the two genes (hereafter: exon siblings) using exon position
and collecting sequence information from the exons. The backsplice junction is then annotated according
to the transcripts provided, indicating exonic/intronic overlap within each transcript exon/intron. For each
exon both up and downstream splice junctions are recorded. This allows for evaluation of the canonical
transcript junction vs backsplice junction. This process is demonstrated in Figure 3.7B.
Evaluating the backsplice read and determining minimum overhang
Each read mapping to a backsplice junction is split into its constitutive exons. An overhang distribution is
then calculated for each exon, this provides a maximum and minimum value showing how far into the exon
all backsplice reads extend (Figure 3.7C). Each exon fragment is then locally realigned to its exon sibling
starting with an initial 15 nucleotide fragment from the splice site. The length of the fragment is then
increased in a step-wise fashion to the maximum overhang. This provides the minimum overhang required
for a satisfactory number of nucleotide differences between backsplice and canonical exon to indicate this read
overhang was correctly mapped (Figure 3.7D). A threshold of 2 nucleotide changes was required to define
the minimum overhang length. A dynamic programming, local alignment algorithm from the Biopython
package with the gap opening penalty -1 and gap extension penalty -4 was used. [Cock et al., 2009]
Each overhang is evaluated in this way to determine if it can be anchored on either end of the
backsplice (Figure 3.7E). All reads that passed the minimum overhang length on both exons were flagged
and counted. A large subset however only identified a single significant overhang, in order to salvage these
reads the mate pair was evaluated.
Evaluating the mate read to validate backsplicing
The mate read was used to determine if the read pair supported the backsplice (Figure 3.7F). Similar to
the exon fragment analysis, I need to identify if the mate read maps uniquely to the gene that supports
the backsplice junction. The mate sequence was aligned to the exon sibling i.e. Gene A exon 2 vs Gene B
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exon2. In order to reduce computational cost a heuristic string matching algorithm was used to determine if
there was enough difference to warrant pairwise alignment. This method elucidated high quality backsplice
alignments that could be enumerated to determine the prevalence of each backsplice/transplicing event.
Evaluating trans-splicing
In much the same way, this pipeline allows for the evaluation of trans-spliced junctions purported to map
between proximal, highly similar genes. These junctions have been largely ignored or considered mapping
artefact. This is curious as mapping algorithms are technically biased towards mapping reads to known
canonical splice junctions and hence a certain amount of evidence is required for the presence of these
non-canonical junctions [Dobin et al., 2013]. Therefore, further investigation of these features alongside the
backsplice junctions was undertaken.
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Figure 3.7: Additional pipeline steps to validate backsplices between homologous genes. Annotations are
downloaded from GENCODE v19 for each gene. (A) The scaffold read and genomic read are evaluated
to ensure they map with satisfactory quality. (B) The genes involved in the backsplice are compared to
identify exon pairs with high similarity (hereafter: sibling exons), this provides an exon to compare against
the current alignment. (C) Maximum overhang per exon fragment is determined using reads aligned to
the scaffold. (D) Exon siblings are pairwise aligned, differences are noted, a minimum overhang length is
determined that anchors a read to a specific exon. (E) This minimum overhang can then be used to determine
which reads have sufficient evidence to come from a particular exon. In most cases only one side can be
uniquely anchored (coloured overhangs) while the other cannot (black overhangs). (F) The mate read can
then be pairwise aligned to the exon sibling to ensure if it is sufficiently unique.
53
3.3 Results
3.3.1 High confidence circRNA
All circRNAs identified in the brain dataset were collected into a database described as ”CircBrDB”. Ta-
ble 3.1 outlines the breakdown of processing circRNA, starting with 107,000 circRNA identified during the
discovery step of the pipeline, a total of 1,100 circRNA were detected at high levels, above control junc-
tions (standard splice junctions from brain house-keeping genes) see Figure 3.8. I start by investigating
the circRNAs with the most read count evidence. The top 35 circRNAs (with average sample expression
above 200 high quality backsplice reads per sample) are shown in Table 3.2, annotated by gene, constraint
(deficiency of deleterious variation, see Chapter 4), function and disease association. A third of these are
novel to CircBrDB while the remaining are also found in Circbase. CDR1as is incredibly abundant as it is
only expressed in circular form [Memczak et al., 2013].
circRNA
CircBrDB (Identified in brain) 107,560
All circRNAs in Circbase 92,369
Final merged database (CircBrDB and Circbase) 112,652
Total detected circRNA with >5 high quality reads 103,549
Total above stringent mapping error controls 1,100
High confidence targets (>100 counts) 80
High confidence targets (>200 counts) 35
Table 3.1: Breakdown of circRNA backsplices identified in brain.
3.3.2 Backsplice junctions forming between closely related genes and gene-
pseudogenes are abundant in the brain
Several of the top hits in Table 3.2 originate from circRNA formation between two proximal (10-50kb
apart) but separate genes. These genes often belong to the same gene family and have identical exon
structure. It was also observed that backsplicing occurs between a gene and its proximal pseudogene.
Examples include; CKMT1B-CKMT1A, TUBB2A-TUBB2B and TUBA1B-TUBA1A. Interestingly, both
tubulin families (TUBA and TUBB) have a large number of high quality backsplice counts. These backsplice
junctions persist in the data even under very strict filters (mapping quality (MAPQ) > 30, alignment score
(AS) > -10) designed to correct for homology. The distribution of novel to known circles found between
genes is shown in Figure 3.9.
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Figure 3.8: Venn diagram outlining the overlap backplice junctions (denoting circRNA) found in CircBase
(public repository) and CircBrDB (database used in this study).
Inclusion of gene-pseudogene backsplices in the top 35 indicate these pseudogenes may have a yet
unexplored function. Proximal genes (and gene-pseudogene pairs) are always located on the same strand
suggesting that transcript read-through could generate one pre-mRNA molecule. A recent publication points
to this happening in proximal genes in cancer [Grosso et al., 2015]. Due to the high sequence identity between
these genes a method had to be developed to verify these results. To the author’s knowledge no tool exists
to tackle this specific alignment query.
3.3.3 Pairwise realignment of backsplice junctions
A further processing step was created to determine the validity of backsplice junctions between highly similar
genes. Results will be focused on the two most highly expressed backsplice junctions in the Tubulin gene
families. Tables 3.3, 3.4 and 3.5 show the backsplice junctions present that pass realignment analysis in the
TUBA gene pair, TUBB gene pair and TUBB2B and pseudogene pair respectively. Scaffold reads, that
map to the backsplice uniquely, are the strongest evidence followed by mate reads which show that both
reads from a mate pair map in a configuration consistent with the backsplice. The majority of backsplice
junctions are too similar to distinguish from aligner artefact. However, the TUBA gene pair shows expression
of several backsplices with scaffold support. The TUBB genes show a single strongly supported junction
while the high similarity between TUBB2B and its pseudogene show inconclusive results.
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Figure 3.9: A Venn diagram outlining the known occurrences of backsplice junctions between proximal genes
in CircBase (public repository) and CircBrDB (database used in this study).
Pairwise realignment of transplicing junctions
Similarly, the results for transplicing realignments are shown in Tables 3.6, 3.7 and 3.8 for TUBA gene pair,
TUBB gene pair and TUBB2B - pseudogene pair respectively. These junctions, are more abundant and
appear to be more pervasive. Interestingly, very few show scaffold reads indicating the scaffold is not specific
enough to anchor a read on both sides. It is noted that TUBB2B and pseudogene show scaffold reads in
both backsplice and transplicing junctions.
3.3.4 Reciprocal back/transplicing junctions across Tubulin genes
Based on the results from the pairwise realignment, both backsplice and transplicing junctions appear in a
reciprocal configuration. Figures 3.10 and 3.11 show the proposed model, whereby the transplice and back-
splice products could be created simultaneously from a splicing reaction between the two mRNA transcripts.
Figure 3.12 shows the genomic context around these genes with the percent of total transplicing junctions
compared to canonical splicing.
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Figure 3.10: Reciprocal splicing in TUBB gene pair. TUBB2A (green) and TUBB2B (orange) show transplic-
ing (red) and backsplicing (blue) junctions. Total numbers of junctions found across all samples are included.
Transplice and backsplice junctions are grouped into reciprocal pairs (yellow text).
Figure 3.11: Reciprocal splicing in TUBA gene pair. TUBA1B (orange) and TUBA1A (green) show transplic-
ing (red) and backsplicing (blue) junctions. Total numbers of junctions found across all samples are included.
Transplice and backsplice junctions are grouped into reciprocal pairs (yellow text).
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Figure 3.12: Comprehensive illustration of splicing in Tubulin gene pairs within their genomic context.
Transplicing (red) and backsplicing (blue) junctions are shown. The percentage of junctions that are iden-
tified as transplicing are shown in red text.
3.3.5 Novel circRNA found in 18S rRNA
A brain-specifc circRNA (hg19 location chr21:9827249-9827513) was detected 60kb away from the nearest
gene (Figure 3.13), this region is highly enriched for histone marks including H3k36me3. This circle does
overlap both spliced ESTs and a Human 18S ribosomal RNA repeat sequence. This could describe an
additional level of control over ribosomal genes, or it could be involved in rolling circle transcription identified
previously [Hourcade et al., 1973].
Figure 3.13: A UCSC browser track of the brain specific circle located in an 18S rRNA gene.
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3.3.6 Case study: circRNA differential expression in Bipolar disorder
After classifying circRNA across multiple brain regions this database could be applied to other human brain
data to sensitively quantify the presence of circRNA in much the same way as protein coding transcripts can
be used to estimate expression.
A differential expression was performed on high confidence count data from publicly available, rRNA
depleted samples of dorsolateral prefrontal cortex from 4 bipolar patients and 4 controls [Akula et al., 2014].
Interestingly, one of the largest fold-changes occurred in BPTF (Table 3.9), a constrained gene
implicated as being involved in the development of Bipolar disorder [Li et al., 2013]. As FDR significance
cannot be achieved with current counts these results are speculative. The study showed that the linear
BPTF mRNA did not show any significant changes to transcript or gene expression [Akula et al., 2014].
This circle and others have been observed in several datasets [Salzman et al., 2012; Memczak et al., 2013;
Venø et al., 2015] including maternal plasma [Koh et al., 2014]. Recently, it has been reported that several
circRNAs in BPTF are some of the most highly expressed in brain [Rybak-Wolf et al., 2015]. This opens
the possibility of looking at the expression change of circRNA to uncover subtle isoform changes that could
provide insight to their function and regulation.
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Circ ID Database type Circle counts Fits circle (mate) Fits circle (scaffold)
039370 CircBrDB 65 104 104
0026129 Circbase 0 0 0
006692 CircBrDB 126 492 492
0026130 Circbase 0 0 0
072371 Circbase,CircBrDB 267 464 278
048643 CircBrDB 333 870 780
Table 3.3: Backsplice junctions for the TUBA1A/B gene pair. Circle counts are the total reads mapping
to the scaffold read with Mapping Quality higher than 30. Fits circle (mate) indicates the number of read
pairs that map in a configuration consistent with backsplicing. Fits circle (scaffold) indicates the number of
scaffold reads consistent with the backsplice. Circbase is a public repository for circRNA while CircBrDB is
the database generated during this study from brain data.
Circ ID Database type Circle counts Fits circle (mate) Fits circle (scaffold)
050637 CircBrDB 4 6 6
001517 CircBrDB 3 19 19
103425 CircBrDB 2 2 2
022384 CircBrDB 2,352 5,306 4,252
Table 3.4: Backsplice junctions for TUBB2A/B gene pair. Circle counts are the total reads mapping to the
scaffold read with mapping quality higher than 30. Fits circle (mate) indicates the number of read pairs that
map in a configuration consistent with backsplicing. Fits circle (scaffold) indicates the number of scaffold
reads consistent with the backsplice. Circbase is a public repository for circRNA while CircBrDB is the
database generated during this study from brain data.
Circ ID Database type Circle counts Fits circle (mate) Fits circle (scaffold)
083557 CircBrDB 9 9 8
032750 CircBrDB 196 206 0
043960 CircBrDB 4 5 5
Table 3.5: Backsplice junctions for TUBB2B and pseudogene. Circle counts are the total reads mapping
to the scaffold read with mapping quality higher than 30. Fits circle (mate) indicates the number of read
pairs that map in a configuration consistent with backsplicing. Fits circle (scaffold) indicates the number of
scaffold reads consistent with the backsplice. Circbase is a public repository for circRNA while CircBrDB is
the database generated during this study from brain data.
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Circ ID Database type Transplice counts Fits Transplice (mate) Fits Transplice (scaffold)
chr12-49523173-49580393 CircBrDB 7,190 7,190 0
chr12-49523356-49580467 CircBrDB 29 30 0
chr12-49521794-49578846 CircBrDB 6 6 0
chr12-49523051-49580119 CircBrDB 18 21 0
chr12-49523116-49580393 CircBrDB 33 33 0
chr12-49521850-49578902 CircBrDB 37 41 24
chr12-49523116-49580184 CircBrDB 16 16 0
chr12-49522721-49580092 CircBrDB 0 0 0
chr12-49523505-49582759 CircBrDB 18,039 18,039 0
chr12-49522647-49579699 CircBrDB 3,368 3,526 3,526
Table 3.6: Transplice junctions for TUBA1A/B gene pair. Transplice counts are the total reads mapping to
the scaffold read with mapping quality (MAPQ) higher than 30. Fits Transplice (mate) indicates the number
of read pairs that map in a configuration consistent with transplicing. Fits Transplice (scaffold) indicates the
number of scaffold reads consistent with the transplice. Circbase is a public repository for circRNA while
CircBrDB is the database generated during this study from brain data.
Circ ID Database type Transplice counts Fits Transplice (mate) Fits Transplice (scaffold)
chr6-3156386-3227720 CircBrDB 13 13 0
chr6-3154838-3225726 CircBrDB 110 5,638 0
chr6-3155157-3226392 CircBrDB 1,276 1,278 0
Table 3.7: Transplice junctions for TUBB2A/B gene pair. Transplice counts are the total reads mapping to
the scaffold read with mapping quality (MAPQ) higher than 30. Fits Transplice (mate) indicates the number
of read pairs that map in a configuration consistent with transplicing. Fits Transplice (scaffold) indicates the
number of scaffold reads consistent with the transplice. Circbase is a public repository for circRNA while
CircBrDB is the database generated during this study from brain data.
Circ ID Database type Transplice counts Fits Transplice (mate) Fits Transplice (scaffold)
chr6-3179946-3227720 CircBrDB 561 561 561
Table 3.8: Transplice junctions for TUBB2B and pseudogene. Transplice counts are the total reads mapping
to the scaffold read with mapping quality (MAPQ) higher than 30. Fits Transplice (mate) indicates the
number of read pairs that map in a configuration consistent with transplicing. Fits Transplice (scaffold)
indicates the number of scaffold reads consistent with the transplice. Circbase is a public repository for
circRNA while CircBrDB is the database generated during this study from brain data.
Circ ID Database type Gene name Fold change log2 Fold change P value
062023 CircBrDB CDKL3 27.36066672 4.774031481 0.005401941
051617 Circbase,CircBrDB BPTF 18.29080292 4.193046502 0.022672423
044167 Circbase,CircBrDB FAM169A 13.34439136 3.7381616 0.035539273
024169 CircBrDB EIF2AK4 11.19167739 3.484354376 0.01756694
008046 CircBrDB ZDHHC11 9.728720098 3.282250018 0.023440319
033998 CircBrDB BRCA1 7.355875792 2.878897119 0.010804344
089984 CircBrDB ZFP64 6.557646408 2.713178113 0.000326552
103894 Circbase,CircBrDB ITGAX,ITGAD 5.388288956 2.42982722 0.000448939
Table 3.9: Differentially expressed circRNA in Bipolar brain. Data was produced using DESeq [Anders
and Huber, 2010] differential expression of backsplices identified in the dorsolateral prefrontal cortex from 4
patients and 4 control samples. A circRNA in BPTF is identified as differentially expressed and has been
shown as a recent candidate for the development of neurodevelopmental disorders [Li et al., 2013].
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3.4 Discussion
circRNA are a new class of non-coding RNAs generated by backsplicing of an upstream 3’ exon start to
a downstream 5’ exon end. Formation of circRNA is reliant on these exon splice sites being brought into
close proximity. This is catalysed by complementary sequences in flanking introns, either directly through
nucleotide hybridization or via RNA binding proteins. A minority of circRNA can function as microRNA
sponges. Current evidence suggests that circRNA utilize the spliceosome similarly to linear transcripts
thereby controlling gene expression through competition. However, data suggests there are other, undiscov-
ered functions for these noncoding molecules.
This chapter outlines an analysis protocol to produce robust counts for circRNA from RNA-seq
data. A custom 2-step pipeline is used to sensitively recover as much data as possible, emphasizing the use
of paired-end data. This approach is applied to discover the most in-depth list of backsplice events in the
human brain currently available, nearly doubles the number of circRNA backsplice junctions in Circbase
when looking at the most robust and highly expressed circRNA.
A pipeline was designed to systematically investigate trans/backsplicing between pairs of proximal
genes. This is the first algorithm to investigate splicing between highly similar genes although similar analysis
approaches have been created to determine locations of overhangs in repeats using megaBLAST [Wilson and
Stein, 2015; Criscione et al., 2014]. This pipeline is both resource and labour intensive as it cannot be applied
indiscriminately, it is essential to verify transcript structure and gene annotations.
I find reads that consistently map the back/transplices between these genes. There can be several
explanations for this. One possibility is biological or technical noise, high transcription rates of these genes,
partial degradation of transcripts and random ligation events could produce these fragments which can then
be amplified by PCR. However, the fact that I see these backsplices consistently across brains samples with
a distribution of overhang lengths indicate multiple different fragments originate from these backsplices.
Paired-end sequencing, which has been undervalued in identification of circRNA, greatly improves resolution
by providing consistent mate-pairs mapping uniquely in a fashion concordant with these backsplices.
circRNA / backsplice count data is a gross underestimation of transcript abundance. Detecting
circles relies heavily on the backsplice junction although, if paired-end data are available, this could be miti-
gated to some degree. This is further hampered by the need for unique reads when dealing with highly similar
genes. Ultimately, if these splicing events are real they are likely expressed at much higher frequency than
stated. These biases will affect accurate quantification as well as statistics applied to this data, specifically
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differential expression which is designed for canonical gene expression.
For backsplicing to occur splice sites must be proximal. This implies backsplices between genes
requires structural changes in the chromatin. Recent studies have revealed that regions containing highly
expressed genes tend to be folded into loops with the help of the transcription factor CTCF [Tang et al.,
2015]. These regions also tend to be significantly enriched for histone marks which aid transcription. In
cancer the role of CTCF in preventing the formation of trans-gene products due to insulating loops [Qin
et al., 2015] has been investigated.
Another consideration is whether the backsplice would create a circular RNA. This would require
transcript read-through between genes. It was recently shown that read-through between proximal genes
does occur and can be linked to tumor phenotypes [Grosso et al., 2015]. In the available data no significant
evidence of transcript read-through could be detected. This could be due to the low copy number of these
events or the instability of such a long RNA fragment. An alternative hypothesis is that two separate RNA
molecules could interact post-transcriptionally to produce two hybrid linear fragments. In order to answer
these questions laboratory validations will be required.
There is great potential for circRNA based on independent cellular regulation from linear isoforms,
enrichment in blood plasma and saliva and their association with neuronal cells and various RNA binding
factors implicate their importance as key molecules in cellular processes. The recent finding that gene
fusions in cancer can create novel circRNA through complementary Alu elements within the fused introns
indicates structural aspects are crucial in circRNA synthesis. The fact that these cancer-specific circRNA
are tumourgenic and provide resistance to therapeutics only emphasizes the need for further investigation.
[Guarnerio et al., 2016]
Here I expand on the known catalogue of circRNA and related backsplicing in the brain while
exploring a peculiar subclass of RNA molecules potentially generated by splicing between transcripts.
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Chapter 4
Annotating and functional
determination of non-coding features
using variant information from exome
sequencing
4.1 Introduction
The human genome is a vast landscape containing 3 gigabases of sequence. An estimated 1% resides within
genes and other functional units and yet these are so paramount to cellular function they show similarity
across various species. One key aspect to understanding the genome is identifying ways to annotate and
discover patterns of bias in sequence data. Here I explore how a similarly powerful method can give further
insight into cellular function.
4.1.1 Variant conservation as a method to identify constrained sequence
The similarity of genes across diverse species is one of the fundamental observations of evolutionary ge-
netics. This information can be utilized to determine nucleotide conservation across species indicating the
importance to cellular function. Sequence conservation across species is widely used to define functional
genetic elements. Nucleotide substitution rates that are lower than expected by neutral drift indicate the
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cells need to conserve particular sequence motifs. This has spurred computational comparisons of vertebrate
genomes to elucidate classes of functional elements including protein-coding genes, RNA genes, enhancers
and microRNA target sites [Guigo et al., 2003; Nobrega et al., 2003; Siepel et al., 2007]. These methods
have proved highly valuable but lack the ability to identify species-specific conservation or recently evolved
mechanisms.
The use of exome sequencing to identify rare, casual variants has paved the way for the analysis
of complex, heritable traits. Through using the ExAC exome consortium Samocha et al. were able to
estimate the rates of de-novo mutation, produce gene-specific probabilities for different mutation types (such
as synonymous, missense, nonsense, essential splice site and frameshift) and apply these to find genes which
have significantly fewer mutations than expected (See Figures 4.1 and 4.2) [Samocha et al., 2014]. These
”constrained” genes are not only enriched for many disease associated genes but contain hundreds of unknown
genes which have yet to be understood [Samocha et al., 2014]. This resource provides an additional level of
annotation when analysing variant data as mutations within these regions could be highly relevant to disease
causation.
With the creation of large exome consortia such as UCLex and ExAC (See Chapter 1) I am now able
to query variants directly to determine the proportion of variation across sequence features. This provides
an unprecedented opportunity to confirm human-specific elements with base-pair resolution.
Figure 4.1: (A) Distribution of Z scores for missense mutations across genes in the human genome. Z scores
are based on observed vs expected prevalence of single nucleotide polymorphism (SNPs) using ExAC data.
A tail of significantly invariant genes is shown beyond the red line. (B) This highlights a higher prevalence of
non-synonymous missense variation in Autism spectrum disorder (ASD) and intellectual disability compared
to unaffected individuals. Black lines indicate population means. [Samocha et al., 2014]
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Figure 4.2: (A) Distribution of Z scores across genes in the human genome. Z scores are based on observed
vs expected prevalence of SNPs using ExAC data, divided into synonymous(grey), missense(orange) and
protein-truncating(red). (B) The proportion of genes that are highly intolerant to deleterious mutation,
broken down into categories based on ClinGen annotation. Showing the relationship between cellular im-
portance and probability of genes to be highly intolerant to deleterious mutation. This is showcased by
haploinsufficient (HI) genes that consist mostly of constrained genes. [Samocha et al., 2014; The EXaC
Consortium, 2015]
4.1.2 Branchpoints are an essential element to exon recognition and splicing
Branchpoints are one of the crucial exonic features required for the formation of the intronic lariat and
recognition of the intronic 3’ splice site [Reed, 1989]. Disruption of these locations can result in splicing
defects attributed to numerous hereditary diseases [Stenson et al., 2003].
Identification of branchpoints is not trivial as they are intronic and poorly understood. In silico
prediction of these sites have provided a large number of candidates but verifying these sites was intractable
[Corvelo and Eyras, 2008]. Alternatively, lariat-spanning junctions can be mined from total RNA-seq data
[Taggart et al., 2012] or lariat debranching enzymes can be inhibited during sample preparation [Bitton et al.,
2014]. Both approaches are suboptimal in terms of high throughput discovery and have only elucidated a
few hundred results.
Recently two studies have identified tens of thousands of branchpoints genome-wide using two differ-
ent methods. Through the use of individual nucleotide resolution UV cross-linking and immunoprecipitation
(iCLIP) [Ko¨nig et al., 2010] more than 64% of branchpoints across 50,000 introns have been resolved [Briese
et al., 2016]. Secondly, by enriching for intronic lariats (via RNase R digestion) and reverse transcribing
the branched junction (CaptureSeq) Mercer et. al were able to determine branchpoint location (Figure 4.3)
[Mercer et al., 2015]. This identified 59,359 high-confidence human branchpoints in >10,000 genes. Their
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results supported previous reported studies that the conservation of the U2 binding site; the upstream U
and branchpoint A (UnA, referred to as Bbox) remained the most conserved. However, it was also noted
that splicing is resistant to Bbox mutations [Berglund et al., 1997; Gao et al., 2008]. Another recent study
looked at the impact of branchpoint distance from the 3’ splice site. Proximal branchpoints were six times
more likely to be spliced [Rosenberg et al., 2015] indicating that clear effects on splicing can be observed at
these locations.
These breakthroughs have made the study of branchpoints possible. For the first time, I am able to
evaluate these cryptic features using human polymorphism data.
4.1.3 Exploring splice site variation by integrating genomic variation with gene
expression data
High-throughput functional interpretation of variation has only recently become feasible thanks to the rise of
next generation sequencing. The GEUVADIS consortium combined RNA-seq from lymphoblastoid cell lines
of 462 individuals from the 1,000 Genomes Project [Abecasis et al., 2012] with their variant data [Lappalainen
et al., 2013] (see Section 1.4.2 for more information). This landmark study illustrated the relationship and
effect of exonic variation on gene expression. Analysis performed focused on expression quantitative trait loci
(eQTLs), the effect of regulatory and loss of function variants and allele-specific effects. This was succeeded
by a second study [Rivas et al., 2015], looking at protein truncating variation (PTV), using GEUVADIS
data in combination with gene expression and exome data from the Genotype-Tissue Expression (GTEx)
consortium [Genotype-Tissue Expression Consortium, 2015].
Interestingly, their focus on how premature stop codons can trigger nonsense-mediated decay (NMD)
supports previous findings that these variants tend to occur roughly 50bp upstream of the 3’ exonic splice
site [Nagy and Maquat, 1998]. They improve this prediction substantially while noting that rare PTVs are
more likely to trigger NMD. They also note the effect of variation around splice sites, defining variants which
affect exon expression and how this relates to the allele frequency of the variant (see Figure 4.4) . Overall this
study emphasises the importance of nucleotides close to the splice site motif but does not discuss how this
information can be used to improve current prediction or how sequence affects the probability of mutation.
An alternative approach to determining variant effects on gene expression, specifically through in-
vestigation of alternative exon splicing, was done using a neural network called ”SPANR” (Figure 4.5). This
algorithm combined variant information with thousands of annotated RNA binding factors, splicing related
features and splice site annotations. Each variant was then classified according to the features they dis-
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Figure 4.3: Identification of branchpoints using (A) CaptureSeq and (B) RNase R to digest linear mRNAs and
selectively enrich circular RNAs including lariats. (C) Reads are aligned to the human genome to identify
branchpoint locations with the 3’ termini indicating the branching nucleotide.(D) Examples of identified
branchpoints in the EEF2 gene. [Mercer et al., 2015]
rupt and other surrounding RNA features. This information was then combined with splicing information
from multiple cell types to train the model to estimate the effect for each variant. This process produced
robust and impressive results but remains computationally very expensive and limited to predicting inclu-
sion/exclusion of alternative exons. The question of how much variation can be captured using just splice
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Figure 4.4: An integrated analysis of Genotype-Tissue Expression (GTEx) consortium data. (A) Shows the
proportion of variants that effect splicing efficiency and their nucleotide position relative to the splice site.
(B) Shows a classification of the types of events that results from splicing. [Rivas et al., 2015]
site information is not addressed. [Xiong et al., 2014]
Figure 4.5: (A) Top: A pipeline using machine learning techniques to predict splicing changes by correlating
DNA/RNA features with splicing levels in healthy tissues. (A) Bottom: This technique can be applied to
filter lists of variants to identify those with a high probability of resulting in splicing changes within genes.
[Xiong et al., 2014]
A significant study was recently published that explored alternative exon regulation through intro-
duction of systematic variation in thousands of minigenes transfected into human HEK293 cells. Through
the analysis of thousands of data points a model was designed to predict exon skipping effects and variant
effects on splice sites. This model used the ratios of exonic hexamers, which appear to function in an additive
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way in splicing. These hexamers included core sequences for exonic enhancers/silencers, branchpoints and
cryptic splice sites and outperformed the machine learning algorithm ”SPANR” mentioned earlier [Rosenberg
et al., 2015]
Rosenberg et. al noted that although degenerate sequences in the introns had an impact on splicing,
there are indeed many more splicing enhancer/silencing sequences than previously discovered that operate
within exons and have a stronger impact than intronic sequence. They were able to predict SNP effects
within the alternate exon and splice sites with high accuracy better than that of the state of the art software
MaxEnt [Yeo and Burge, 2004]. Similar to SPANR their software resides as a web service, with limited use
to predict exon skipping as it requires exon definition for all three exons. This imposes limits on number of
calls that can be made at one time and lack of automation as it must be manually submitted. [Rosenberg
et al., 2015]
4.2 Methods
In addition to the software and tools described in section 2.1.1, this section lists the methods that have been
specifically used for this chapter.
4.2.1 Calculating the cumulative variant ratio across features of interest
In order to determine whether variants could provide insight into feature conservation both UCLex and
ExAC [The EXaC Consortium, 2015] datasets were interrogated. For each feature a 20bp flanking region
was defined. The cumulative ratio of variants to reference calls was calculated for each position across all
features. Features tested include; splice-sites of internal exons, branchpoints and the first 60bp of internal
exons for all highly constrained genes [Samocha et al., 2014].
4.2.2 Elucidation of potentially deleterious branchpoint variants
In order to gain the highest resolution branchpoint features from both described high throughput studies
[Briese et al., 2016; Mercer et al., 2015] were merged. This resulted in a final set of over 90,000 branchpoints.
Schematic of the process is shown in Figure 4.6.
Through visual inspection of the cumulative ratio plots it became clear the 1st motif position (up-
stream U) and 3rd position (branchpoint A) (UnA) remain the most conserved, in agreement with previous
studies [Berglund et al., 1997; Gao et al., 2008]. Through mining these positions in the available consortia,
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Figure 4.6: Merging branchpoints to achieve an annotated and comprehensive list of all variants. Identified
branchpoints from one study (red) are merged with a second (orange), overlapping branchpoints are merged
into a single site (blue).
filtering for extremely rare homozygous variants, I was able to select a small number of potentially dis-
ease causing candidates present in branchpoints. Ultimately, to determine their effect on splicing further
investigation was necessary.
4.2.3 Interpreting splice site variation through integration with gene expression
data
A custom pipeline was developed to integrate exome-based genomic variation from the 1,000 genomes project
with polyA RNA-seq from the GEUVADIS study [Lappalainen et al., 2013]. This data was then applied to
splicing related features to determine the functionally observable effect of mutation.
This pipeline consisted of custom python scripts with extensive use of Pysam, Biopython and Bed-
tools libraries [Cock et al., 2009; Quinlan and Hall, 2010; Li et al., 2009].
Defining splice site and branchpoint annotations and gathering variant information
A full list of exonic splice sites was retrieved from the GENCODE v19 annotation [Harrow et al., 2012]. All
known branchpoints from both studies [Mercer et al., 2015; Briese et al., 2016] were merged into a single
database using Bedtools. This merged annotation was used for all further investigation.
A strict sequence definition was then created for both splice sites and branchpoints based on ac-
cumulated data from variant graphs and literature. Variants occurring in the last exonic position or two
first intronic positions of both 5’ / 3’ splice sites were recorded. Similarly, for branchpoints only variants
occurring at the central A or upstream U (UnA) were recorded and used for further analysis. This strict
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definition was chosen to ensure the variants directly affected the features as several other exonic features in
close proximity may also overlap extended splice motifs [Xiong et al., 2014]. These variants were grouped
into a splicing associated variation database and used for all further analysis.
Exon expression analysis of potentially deleterious mutation
Exon expression data from the GEUVADIS project was analysed to determine if there was a visible effect
on gene/exon expression in the data. These data consisted of library depth and Peer-factor normalized read
counts. For each variant all samples with at least one allele (heterozygous or homozygous) were grouped
and compared to remaining wildtype samples across the gene of interest containing the splicing variant.
Annotation of variants and creation of a variant splice site score
Splice sites annotation
In order to focus on rare variants most likely to result in deleterious change a threshold was set for
variations with fewer than 10 homozygote samples.
For each variant the entire splice site sequence was extracted. The variant was applied to the human
reference sequence to create a mutated splice site. With small indels care was taken to replace nucleotides
in a manner to maintain exon integrity. Table 4.1 shows the bases extracted from each splicing feature.
Splicing feature Number of exonic bases Number of intronic bases
5P 2 exonic 7 intronic
3P 2 exonic 20 intronic
BP 0 5 intronic
Table 4.1: Sequence extracted from each splicing feature for further analysis.
Both 3’ and 5’ splice sequences were scored using the splice site scoring tool MaxEnt [Yeo and Burge,
2004]. MaxEnt models sequence motifs based on the principle of maximum entropy. The maximum entropy
distribution is determined using a set of constraints estimated from available splice site data. MaxEnt
outperforms naive motif summarising approaches by taking the surrounding sequence of each nucleotide
position into account. The difference in splice site score was calculated between wildtype and variant splice
sites. This was used to indicate the degree of deviation from the functional splice site.
Branchpoint annotation
A position specific scoring matrix commonly used for motif discovery was applied on the annotated
branchpoint database. A degenerate consensus was created. This was concordant with current research indi-
cating the first and third positions were generally ”U” and ”A” respectively. The score was normalized using
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the average intronic GC content (GC 40%). Scoring was done according to a PWM formula originally used
for splice sites and other biological sequence [Shapiro and Senapathy, 1987]. The algorithm was implemented
using Biopython [Cock et al., 2009], the equation is shown below:
score = 100× V ariantPWMscore−MinimumPWMscore
MaximumPWMscore−MinimumPWMscore
Mining BAM files for splice junction data
For each variant position GENCODE v19 annotation was used to identify the gene, exon of interest and
upstream exon. All data from the gene of interest were extracted from the 426 BAM files (mapping statistics
are available in Appendix Table 2). All junction reads that have at least a 15bp overhang on either side of
the intron and were in proximity to the exon of interest were retained. Read counts were extracted from the
shores of the exon of interest and the neighbouring exon connected by the junction.
In order to make this analysis tractable optimization was essential as storage and processing of 426
RNA-seq samples was over 2 terabytes of binary compressed data. In order to minimize resource requirements
all genes of interest were extracted from all BAM files to create a smaller, easily accessed copy. All junctions
and read counts were recorded in hash tables for efficient storage.
After collection of the raw data the canonical splice junction (hereafter; JunctionA) was identified.
This was defined as the most highly expressed junction across all samples. Several other statistics were
collected based on this junction and are described in Table 4.2 and Figure 4.7. As all splicing starting from the
same splice site was in direct competition, this allowed the calculation of canonical junction ratios compared
to other non-canonical junctions from the same splice site. These splicing ratios were implemented at both
the effected variant splice site and the upstream splice site connecting the junction (UPSTR). Furthermore,
it was noticed that in some cases splice junctions were shifted a short distance from the splice site (due to
the effect of the variant). In order to capture these a separate statistic (JA Ratio) took these junctions into
consideration.
Shifted junctions were defined as junctions that originate within 20bp of the exon of interest splice
site and splice in the same direction as the canonical splice junction. A similar approach was taken for the
Branchpoint variants as these were associated with the downstream 3’ splice site. Filtering was done to
remove all samples with low upstream exon expression (< 1.15 normalized exon shore coverage) indicating
insufficient expression for analysis.
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Statistic Description
UPST Ratio A ratio of JunctionA/all junctions from the neighbouring junction exon splice site
Variant exon Read count of the last 100bp of the exon of interest, normalized by total mapped reads
UPST/EOI exon Read count of the last 100bp of the neighbouring exon, normalized by total mapped reads
JA Ratio A ratio of JunctionA/(JunctionA + shifted junctions*)
Table 4.2: Statistics generated from splice junctions and exon expression. *Shifted junctions are defined as
junctions that originate within 20bp of the exon of interest splice site and splice in the same direction as the
canonical splice junction.
Figure 4.7: Calculation of multiple ratio statistics dependent on which splice site is being investigated. A.
Upstream splice site (UPST). B. Variant location (exon of interest i.e. EOI) and C. Looking only at shifted
junctions from the variant location (JA Ratio). D. Exonic shores within the variant and upstream exon
(Variant exon, UPSTR exon).
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Statistical testing to determine significant difference and correlation
A Wilcoxon ranked test was applied to test each statistic; data were divided between wildtype and variant
(heterozygous and homozygous were grouped) samples. This provided a P value to gage the difference in
expression between these groups indicating whether a change is in fact present.
I correlated the score of each variant to each statistic by fitting a linear model. Initially there was
no significant trend in the data. This was largely due to high variance in gene expression leading to inclusion
of uninformative samples, this made distinguishing lack of signal from lack of coverage intractable. I filtered
aggressively using the P values from the Wilcoxon test (p value < 0.0005) to allow the selection of variants
that show differential expression between wildtype and variant alleles. From this filtered data significant
correlation between variant score and splicing statistics was obtained.
Given the P value distribution tends towards bimodal/non-normal further verification was necessary.
In order to verify results each statistic was bootstrapped 1,000 times with replacement to achieve an average
r-squared. In order to get a measure of sensitivity a leave one out cross validation was also performed.
4.3 Results
4.3.1 Variant ratio graphs
Figure 4.8 shows variant frequencies at each codon position closely mimic traditional sequence conservation.
Figures 4.9 and 4.10 show overlapping variant graphs of splice sites and branchpoints from UCLex and ExAC
respectively. The overlay of splice sites with branchpoints is intended purely as context for comparison of
frequency of variation between these two features. It is clear that splice sites have far lower variation than
branchpoints (where conserved positions are about as invariant as exons).
Figures 4.9 and 4.10 have similar trends indicating the robust nature of variant summary regardless
of individual samples. It is clear that the first two intronic splice site positions are highly conserved. Interest-
ingly, the first exonic position is shown as equally highly conserved in the ExAC data. When evaluating the
branchpoint graph it is clear that both the first and third positions are conserved compared to the intronic
context. The first position appears to be more highly conserved in both UCLex and ExAC datasets.
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Figure 4.8: The cumulative ratio of variants across internal exons of highly constrained genes. Each codon
position is represented by a different colour. Codon conservation is clearly observed indicating the sensitivity
of this approach to identify functional conservation.
4.3.2 Potential branchpoint disease variants
By evaluating low frequency changes at the 1st position and 3rd position of all identified branchpoints (within
range of the exome capture) it is possible to identify potentially disruptive mutations.
At least 103 (51: 1st position, 52: 3rd position) homozygous branchpoint changes were identified in
the UCLex data, 20 % of these fall within the constrained gene category.
For the ExAC data, 191 variants (83: 1st position, 108: 3rd position variants) are found with 5
or less homozygous calls and less than 100 heterozygous calls. 10% of these fall within constrained genes.
Interestingly, 59 variants are found on the X chromosome, this introduces the added complexity of the male
as hemi-zygous for variants on the X chromosome. However, heterozygous counts for these variants are
also extremely low (<8 heterozygous calls) and a similar imbalance is not present in the UCLex data. This
phenomenon remains unexplained, possibly indicating a variant calling artefact or an X-linked disease cohort
in ExAC.
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Figure 4.9: UCLex data variant graph showing the ratio of variants across splice sites (blue line) and
branchpoints (green line). Yellow positions indicate intronic positions, the branchpoint site is highlighted in
purple, exonic nucleotides are shown in orange.
Figure 4.10: ExAC data variant graph showing the ratio of variants both splice sites (blue line) and branch-
points (green line). Yellow positions indicate intronic positions, the branchpoint site is highlighted in purple,
exonic nucleotides are shown in orange.
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4.3.3 Integrated variant and splice junction analysis
Table 4.3 shows the number of relevant splice feature variants retained after filtering for gene expression.
These were filtered further if wildtype and variant groups showed significant splicing difference across any
of the statistics. It is clear that splice site mutations occur very infrequently, more than half occur in genes
that are not being expressed. Further, due to high levels of noise and expression variation it was essential to
select a subgroup of variants that show measurable impact on the splicing phenotype of the gene in question.
This reduces usable data to roughly 10% but provides a solid foundation for further testing.
Feature Total Variants Expression filtering Significant variants
5’ 1607 770 155
3’ 1402 664 130
BP 1001 808 201
Table 4.3: Results from filtering variants associated with splicing features. In order, total rare variation
associated with splice features, total variants after filtering for gene expression in the cell line and total
variants with highly significant (p< 0.0005) change between wildtype/variant groups.
Bar plots in Figure 4.11 provide an overview of general properties associated with variants and their
distribution around the splice site. As expected transition/ transversion (Ti/Tv) ratios remain constant
across filtering and features. Interestingly, 5’ splice sites seem to show the highest conservation at the 2nd
intronic position. While 3’ splice sites show no significant preference but higher indel occurrence, possibly this
can be tolerated more readily by the splicing machinery. Similarly, branchpoints conform to the literature
and variant graphs showing fewer effect-variants on the first ”U” position.
Exon expression does not capture subtle splicing change
In order to determine the effects of rare splicing variants exon expression levels of the gene were investigated.
Figure 4.12 shows three examples of exon expression in genes containing variants within core motifs. It
became apparent that very little detectable difference was present in the majority of cases. I concluded that
either the majority of these variants have no effect, the effect was being masked due to variance in sample
expression or that exon expression does not capture subtle changes to splicing effectively.
Score distributions
If splicing machinery is indeed so robust that the majority of rare variants have no substantial effect a score
would be ideal to measure the effect of the variant on the splicing motif. A score was designed using MaxEnt
[Yeo and Burge, 2004] to score the wildtype and variant splice sites and the difference between them. This
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Figure 4.11: Splice site and branchpoint bar plots for both expression filtered (Raw) and significant P value
filtered data. Three bar plots show proportion of transitions (Ti) ,transversions (Tv) and indels at each
position relative to splice site. (A) 5’ splice site variants (B) 3’ splice site variants (C) Branchpoint variants.
score compares each splice site against a model created using all known splice sites. Functional splice sites
are generally scored above 5. Score distributions were calculated for all variants at 3’ and 5’ splice sites and
are shown in Figures 4.13 and 4.14.
While the distribution shapes are similar it is clear 3’ splice sites appear more narrow. This effect
could also be due to the difference in model efficiency at capturing nucleotide differences at 3’ splice sites.
The bimodal distribution of the difference (red) indicates the propensity of variant changes to have very
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Figure 4.12: Exonic expression for three mutations in core motifs of (A) 5’ Splice site (B) 3’ Splice site
and (C) Branchpoint. Each graph represents exon expression across the length of the gene with consecutive
exons arrange from 1st - last exon on the x-axis and normalized exon read count on the y-axis. Wildtype and
variant samples are summarized by the blue and green line respectively. Standard deviations are included
for each exon. Exon containing the splicing variant is highlighted by a red point on the x-axis.
little (or no) effect or a strong effect.
The score distribution for branchpoints calculated using a position weight matrix is show in Figure
4.15. Although this does show a slight bimodal trend it is clearly far less specific. Figure 4.15 B shows
the decomposition of this distribution into the first position (U) and 3rd position (A) of the motif. It is
interesting that the distributions indicate a clear difference in score effect. This can be explained by the
prominence of the central ”A” in the majority of branchpoints. A change to this nucleotide would have a
drastic impact on the score. This could be an effect of sampling bias, as all current techniques rely on the
central adenine to anchor the branchpoint motif.
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The difference between the wildtype and variant scores allowed quantification of motif deviation. It
was clear that splicing should be affected based on the variant score even though exon expression showed no
effect. The accuracy of this difference score was then tested by looking at splice junctions.
Figure 4.13: Distribution of 3’ splice site scores for wildtype (blue), variant (green) and difference (wildtype
- variant) (red) categories. MaxEnt score shown on the X axis respectively.
Figure 4.14: Distribution of 5’ splice site scores for wildtype (blue), variant (green) and difference (wildtype
- variant) (red) categories. MaxEnt score shown on the X axis.
Variant impact on splicing efficiency
In order to investigate the effect on splicing four statistics were created for each splicing feature (5’ , 3’ and
branchpoint) (please refer to Table 4.2 and Figure 4.7). There are several common effects presented here.
82
Figure 4.15: A. Distribution of Position weight matrix scores for Branchpoint variants. MaxEnt score shown
on the X axis B. Distribution of Position weight matrix scores for both Position 1 (U) and Position 3 (A)
branchpoint variants in red and green respectively. MaxEnt score shown on the Y axis.
Overall, in cases where variation has an impact on splicing a dosage effect is clear between homozygous,
heterozygous and wildtype. Heterozygous splice site mutation appears to result in a 25-50% change from
wildtype. Variant impact on branchpoint mutations appear to be far more muted. This indicates that
splicing machinery can recover more efficiently from these changes. Exonic expression is rarely as accurate
or distinguishable as the splicing statistics.
Splicing variation decreases efficiency
All splicing features show evidence of variation significantly decreasing splicing efficiency. It is also worth
noting that high difference scores for 3’ splice site mutations tended to result in a 3 (or multiple of 3) base
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pair shift into the exon (Figures 4.16 and 4.17). This points to a potential rescue mechanism that keeps the
transcript in-frame.
5’ splice site variants that reduce splicing efficiency tend to be compensated by increased expression
of alternate exon starts (Figure 4.18), exon skipping and intron retention (Figure 4.19) or exon extension
(Figure 4.20).
Branchpoints also show a minor (5-15%) but significant reduction in splicing efficiency (Figures 4.21
and 4.22 ). However, in one case the dosage effect was more striking, resulting in a 25% and 50% reduction
for heterozygous and homozygous respectively (Figure 4.23). This resulted in the creation of an alternate,
novel 3’ splice site within the exon.
Splicing variation improves efficiency
In rare cases a variant change at a splice site seems to significantly increase its efficiency thereby promoting
splicing in an otherwise unused exon. This phenomenon is present in both 3’ (Figure 4.24) and 5’ splice sites
(Figures 4.25 and 4.26) leading to selective use of a single splice site over another (both isoforms are present
at equal levels in the wildtype) and inclusion of cryptic exons respectively.
Correlation of score to splicing efficiency
In order to investigate the effectiveness of the variant effect scores a linear regression analysis of the scores
against each splicing statistic was undertaken. For this analysis only those variants that showed highly
significant (P value < 0.00005) differences between wildtype and variant groups were investigated. This was
necessary as variance within unfiltered results was overwhelming due to technical and biological noise.
Figures 4.27 and 4.28 show the linear regression for each statistic versus score for 5’ and 3’ splice sites
respectively. All statistics are significantly (P value < 0.05) correlated with score. In all cases the upstream
splice site (UPSTR) and shifted canonical ratio (JAR) statistics performed best. This indicates that, as
expected, a significant proportion of splicing variation can be explained by the difference in sequence.
A similar analysis was done for the branchpoint score but none of the statistics showed significant
correlation or r-squared above 0.01. This indicates the mutability of sequence is not a major considera-
tion in the majority of cases, and that several unknown contributing factors are involved such as multiple
branchpoints per intron.
The above analysis was repeated to determine if variant frequency, like score, can predict splicing
efficiency. There is no correlation between damaging splice variants and minor allele frequency (see Figures
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4.29 and 4.30). For both 3’ and 5’ splice sites no significant correlation or r-squared > 0.06 was obtained.
This implies that MAF cannot be used to predict splicing pathogenicity in a similar way as other deleterious
variation [Rivas et al., 2015]. It is possible that splicing mutations are incredibly rare and may be selected
against regardless of effect. Alternately, selection may not operate on these rare, neutral mutations and thus
cannot be distinguished from functional mutations on allele frequency alone.
The distribution of data in figures 4.27 and 4.28 is L-shaped indicating a skew in the P values. This
is possibly due to the bimodal/non-normal tendency of the distribution. For further assurance, each statistic
was bootstrapped a 1,000 times with replacement to achieve an average r-squared. In order to get a measure
of sensitivity a leave one out cross validation was done on the data. This is summarized in Tables 4.4 and 4.5.
Surprisingly, all statistics appear to be sensitive with the exception of the variant exon. This highlights the
lack of sensitivity given by exon expression. This could be due to the inconsistent effects to the variant exon
depending on the type of recovery mechanism the cell uses. For example, the inclusion of cryptic elements
or subtle splice site shifts is unlikely to result in much change.
Splice statistic Mean grad Grad-lowerCI Grad-upperCI Min grad Max grad Final variants
UPST 0.314925627 0.306135018 0.323716235 0.217787552 0.393927925 46
JAR 0.492104854 0.480462679 0.503747029 0.390713733 0.584601649 20
EOI 0.376046549 0.361683527 0.39040957 0.156183516 0.534347488 24
VE 0.028974493 0.026476701 0.031472284 0.008900012 0.093380182 53
Table 4.4: Cross validation of linear regression on Splicing statistics for 5’ splice sites. Slope of regression is
correlated to score to determine r-squared. EOI: A ratio of JunctionA/all junctions from the variant exon,
UPST : A ratio of JunctionA/all junctions from the neighbouring junction exon ,VE: Read count of the last
100bp of the variant exon, normalized by total mapped reads ,JAR: Shifted junction ratio A ratio of Junc-
tionA/(JunctionA + shifted junctions). Columns in order are; Splicing statistic, Mean gradient, Gradient
(lower confidence interval),Gradient (upper confidence interval), Minimum gradient,Maximum gradient and
number of final variants used.
Splice statistic Mean grad Grad-lowerCI Grad-upperCI Min grad Max grad Final variants
UPST 0.668573045 0.663165639 0.673980452 0.586792755 0.738014867 30
JAR 0.349764635 0.335178276 0.364350994 0.145883398 0.630156662 17
EOI 0.375049471 0.36380803 0.386290912 0.264749377 0.509700092 18
VE 0.051390732 0.048977608 0.053803856 0.030615054 0.081498466 41
Table 4.5: Cross validation of linear regression on Splicing statistics for 3’ splice sites. EOI: A ratio of Junc-
tionA/all junctions from the variant exon, UPST : A ratio of JunctionA/all junctions from the neighbouring
junction exon ,VE: Read count of the last 100bp of the variant exon, normalized by total mapped reads
,JAR: Shifted junction ratio A ratio of JunctionA/(JunctionA + shifted junctions). Columns in order are;
Splicing statistic, Mean gradient, Gradient (lower confidence interval),Gradient (upper confidence interval),
Minimum gradient,Maximum gradient and number of final variants used.
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Figure 4.16: Splicing variation decreases efficiency. A. 3’ splice site variant significantly decreases canonical
splicing (UPST ratio) and creates a shifted junction (JA ratio). B. This results in a shifted exon start by 12
nucleotides.
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Figure 4.17: Splicing variation decreases efficiency. A. 3’ splice site Variant significantly decreases canonical
splicing (UPST ratio) and creates a shifted junction (JA ratio). B. This results in a shifted exon start by 3
nucleotides.
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Figure 4.18: Splicing variation decreases efficiency. A. 5’ splice site Variant significantly decreases canonical
splicing (UPST ratio) and expression of the affected exon (variant exon). B. This results in an increase of
alternate junction expression.
88
Figure 4.19: Splicing variation decreases efficiency. A. 5’ splice site Variant significantly decreases canonical
splicing (UPST ratio) and expression of the affected exon (variant exon). B. This results in intronic retention
and complete loss of splicing.
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Figure 4.20: Splicing variation decreases efficiency. A. 5’ splice site Variant significantly decreases canonical
splicing (UPST ratio). B. This results in exon extension and loss of splicing.
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Figure 4.21: Splicing variation decreases efficiency. A. Branchpoint variant slightly decreases canonical
splicing (UPST ratio). B. This results exon skipping in a small percentage of cases.
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Figure 4.22: Splicing variation decreases efficiency. A. Branchpoint variant slightly decreases canonical
splicing (UPST ratio) and shows an increase in 3’ splice site shifts (JA ratio). B. This results in use of
cryptic 3’ splice site in a small percentage of cases.
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Figure 4.23: Splicing variation decreases efficiency. A. Branchpoint variant slightly decreases canonical
splicing (UPST ratio). B. This results in use of the primary splice site, removing an alternate 3’ splice site.
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Figure 4.24: Splicing variation improves efficiency. A. 3’ splice site variant increases canonical splicing (UPST
ratio,JA ratio). B. This results in preferential splicing to this location.
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Figure 4.25: Splicing variation improves efficiency. A. 5’ splice site variant increases canonical splicing (UPST
ratio,JA ratio). B. This results in inclusion of an alternate exon not present in wildtype.95
Figure 4.26: Splicing variation improves efficiency. A. 5’ splice site variant increases canonical splicing
(UPST ratio,JA ratio) and expression of an alternate exon (variant exon). B. This results in inclusion of an
alternate exon not present in wildtype.
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Figure 4.27: Linear regression of 5’ splice splice site variant score against difference in means (wildtype group
sample mean - variant group sample mean) for; A. Upstream splice site B. Upstream splice site (including
only shifted junctions) C. Variant exon splice site ratio D. Variant exon shore.
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Figure 4.28: Linear regression of 3’ splice splice site variant score against difference in means (wildtype group
sample mean - variant group sample mean) for; A. Upstream splice site B. Variant splice site (including only
canonical and shifted junctions) C. Variant exon splice site ratio D. Variant exon shore .
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Figure 4.29: Linear regression of 5’ splice site variant frequencies from ExAC against difference in means
(wildtype group sample mean - variant group sample mean) for; A. Upstream splice site B. Upstream splice
site (including only shifted junctions) C. Variant exon splice site ratio D. Variant exon shore .
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Figure 4.30: Linear regression of 3’ splice site variant frequencies from ExAC against difference in means
(wildtype group sample mean - variant group sample mean) for; A. Upstream splice site B. Upstream splice
site (including only shifted junctions) C. Variant exon splice site ratio D. Variant exon shore .
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4.4 Discussion
4.4.1 Variant ratio graphs are a novel method to annotate human specific fea-
tures
Here I outline an approach to identify ’conserved’ genomic positions within splicing features using the fre-
quency of polymorphisms across many individuals. Having successfully identified the expected conservation
of the first two intronic splice site nucleotides I have expanded to show that branchpoints also show a pat-
tern of conservation centring on the U and A positions consistent with the literature. This has lead to
the identification of over 400 rare, branchpoint mutations in two large consortia which can be investigated
further.
The caveat of this approach is the requirement of precise location for genomic features. In order
for variant graphs to highlight important nucleotides they must overlap precisely. Using currently available
data, a single genomic location cannot be explored in the same way as phylop/GERP species conservation
can. This technique provides a unique opportunity to explore nucleotide constraint as a complementary
approach to classic species conservation.
4.4.2 More data are necessary to model branchpoints effectively
Branchpoints are emerging as important features that, when disrupted, have a measurable impact on splicing.
This study identifies instances where branchpoint variation results in significant (albeit not drastic) change
to splicing. Currently, there is not sufficient information to build a successful model for variant effects on
branchpoints. Most noticeably, sequence variation appears to be higher than splice sites even at invariant
positions. This could indicate that splicing machinery can compensate more effectively to rescue these effects.
Branchpoints may be far more mutable for several reasons; there could be multiple ”rescue” branch-
points per intron or other splicing signals (i.e. polypyrimidine tract and 3’ splice site) may be sufficient
to compensate for weak motifs. At least 40% of branchpoints remain unidentified, this number is likely
an underestimate due to lack of knowledge about tissue specific branchpoints. Furthermore, a number of
branchpoint variants are missed as they are outside the exome capture range (generally exome baits only
capture 50bp around an exon). The use of whole genome sequencing may alleviate this by improving relevant
intronic variant information. Lastly, both studies that have identified the largest percentage of branchpoints
tend to bias the branchpoint location toward the nearest adenine residue. This could mean that several
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sites have been mis-annotated and reinforces the need for further discovery and high-throughput validation
methods.
4.4.3 Splice junctions accurately define splice changes
After investigation of exon expression in genes with splicing variants it became clear that the majority had
no visible effect. This resulted in two hypotheses; splicing variation often has no effect or the effect is
not captured by exon expression. A pipeline was designed for the quantification of splice junctions which
showed striking differences in splicing efficiency as well as various splicing compensation mechanisms such
as triplicate nucleotide shifts at 3’ splice sites.
A score was created to predict the divergence caused by variants from the wildtype splicing feature.
This proved effective for splice sites but not for branchpoints. It is clear the distribution of scores for both
3’ and 5’ splice sites appear to be bimodal, having either a negligible or drastic effect on the splicing motif.
However, the score still requires a continuous scale to capture the direction of effect. Interestingly, variation
can also enhance splicing efficiency. This effect, although rare, could be just as pathogenic, resulting in the
inclusion of cryptic elements thereby creating aberrant transcripts.
4.4.4 Minor allele frequency is not a predictor of splice site pathogenicity
On average the motif score explained roughly 40% of variance. Unmeasured effects such as exonic en-
hancers/silencers, RNA binding proteins and epigenetic environment (i.e. prevalence of histone marks,
methylation) is not be captured. The focus of the study on the nuclear splicing motif is intentionally strict
to reduce false positives resulting from altering these features.
This analysis is made possible by significant advances in the field [Lappalainen et al., 2013; Rivas
et al., 2015]. These studies showed the power of integrating variation with gene expression. However,
their hypothesis that allele frequency can be used to determine deleterious effect does not hold true for
splicing variation. Based on current data, minor allele frequency is not an effective predictor of splicing
pathogenicity. These mutations are incredibly rare and likely innately selected against. This may change
with future expansions of exome consortia if enough rare variation can be captured.
4.4.5 Technical and biological variation impact data quality
Although GEUVADIS is a breakthrough study it does suffer from technological and computational biases.
This is particularly evident in gene expression data. The sequenced data was produced on older, less robust
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Illumina machines at lower depth with shorter reads. This increases the level of missingness and reduces
usable data. Another consideration is the older algorithms used for alignment and variant calls. The recovery
of splice junctions is dependent on both the algorithm employed and the length of the reads. Alignment
algorithms do not fully recover these reads, especially those with short overhangs. Furthermore, novel
junctions are easily missed if read coverage or gene expression is not high enough to pass noise thresholds.
For the exome variant data; several insertion/deletions within the data were clearly low quality or incorrectly
called and were excluded from this analysis.
Compound variation or multiple proximal SNPs may result in false positive associations as reported
by Rivas et al [Rivas et al., 2015]. Although not explicitly tackled by this analysis, is very rare (a single
occurrence was noted) and has a minimal effect at locations used for this study.
A large source of variation, exacerbated by lack of read coverage, is the variable expression of several
genes across the cell population. This makes distinguishing lack of signal from lack of expression challenging.
In order to compensate only variants that showed appreciable change between variant/wildtype groups were
selected to estimate predictive value of the variant score.
4.4.6 Variant splicing score captures significant splice junction change
Multiple statistics were generated to describe splicing efficiency. All statistics used a canonical junction
to define a ratio of canonical splicing over other, potentially aberrant splicing. Statistics were centred at
the splice site where the variant occurs or at the opposite splice site described by the canonical junction.
Interestingly, the highest concordance is different between 3’ and 5’ junctions. 5’ splice sites appear to be
best described by including shifted junctions (JAR 66%) in the vicinity of the splice site. 3’ Splice sites are
best described by their upstream canonical splice site (UPST 49%). Potentially the exon may be skipped or
a cryptic event occurs within the intron that is not proximal to the original splice site and is not accounted
for by the shifted junction statistic.
The poor correlation of variant exon expression to splicing change is truly striking. On average it
shows a 2-3 fold weaker correlation than splice junction statistics. This indicates that a great deal of change
is currently being missed by focusing on approaches that look at exonic/isoform expression alone.
4.4.7 How the current study compares to recent publications
The recent study by Rosenberg et al. [Rosenberg et al., 2015] attempted to predict variant effect based on
variation in and around splice sites. They report similar concordance results based on sequence changes at
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splice sites from GEUVADIS data (concordance of 40% from MaxEnt, their software, HAL achieves 60%).
Although MaxEnt is outperformed it still achieves an almost equivalent accuracy on heterozygous SNPs ;
81.7% vs 87.1%. This is impressive as HAL is trained on a vast, custom designed library of minigenes.
Rosenberg et al. apply MISO [Katz et al., 2010] to quantify splicing in GEUVADIS data. Although
this is a particularly robust tool it does not quantify cryptic events accurately. MISO focuses on known
isoforms and expected exon skipping events. This is a major disadvantage as the majority of splicing
mutations generate cryptic splice sites which will not be measured. This likely accounts for the higher
concordance found in this study as all splice junctions were included in the analysis. Furthermore, HAL
includes surrounding exonic and intronic variants making direct comparison difficult.
The pipeline designed here does not require access to a website and can be run very efficiently on
thousands of SNPs, potentially as part of a standard annotation pipeline for exome data. Any interesting
results from this initial analysis could then be selected manually and validated using the HAL online software.
4.4.8 Optimization is essential for reproducibility of this analysis
A significant part of what made this study feasible was computational optimizations. Analysis of over four
hundred BAM files is challenging for several reasons. Firstly, the amount of space required for processing
is excessive, well over 2TB just to host the data. This was circumvented by selecting only regions that
contained variants of interest across the entire cohort. This was necessary to reduce processing times and
storage requirements. Optimizations in terms of analysis focused on running steps in parallel and producing
large hash tables (very efficient data structures in Python) to avoid reprocessing unnecessarily. The end
result is an analysis which took just over 3 days of wall clock time to process several terabytes worth of raw
files. And could be rerun (excluding initial processing and downloading) within hours.
4.4.9 Conclusion
These observations serve as a fundamental starting point for further work into the improved annotation of
splicing variants. This will allow for efficient detection of effects on splicing, including currently unexplored
instances where variant changes can create novel splice sites/cryptic exons.
Integration of further data may drastically improve variant score prediction. Inclusion of epigenetic
environment such as prevalence of histone marks and methylation in a cell type specific manner will further
increase correlation. Defining a robust score can be used to rank splicing variation and identify mutations
that create novel splice sites within exons or introns. These variants remain largely undetected and result in
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various disease phenotypes such as Autosomal recessive bestrophinopathy and X-linked retinitis pigmentosa
[Davidson et al., 2010; Webb et al., 2012].
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Chapter 5
Conclusion
5.1 Core features and central concepts of the thesis
5.1.1 Splicing as the primary force behind species diversity
Splicing has been known as an integral part of species diversity for over thirty years [Chow et al., 1977;
Berget et al., 1977]. It shows the complexity that can be reached without the need to increase raw gene
numbers and provides a remarkable way to enhance cellular complexity and transcriptional control. Here, I
look at splicing from multiple angles to show we have only scratched the surface of this exciting and dynamic
process.
Splicing can be a mechanism to control transcript integrity through the inclusion/exclusion of poison
exons. This mechanism, known as recursive splicing, shows how splice sites can be reconstituted by other
splicing reactions and splice site competition can play a vital role in guiding the cellular machinery. I
then explored how the structure of co-transcribed RNA can create circular molecules through a backsplice
junction. This creates a further layer of complexity, showing how RNA structure plays a crucial role in
splicing processes. Lastly, I looked at the three core features of the splicing reaction, namely; 5’ and 3; splice
sites and the branchpoint. The branchpoint has been poorly characterised although it has been shown to
be disease causing. I explore the impact of variation at these features, demonstrating that the functional
effect of sequence variation can be predicted to some degree. Ultimately, the diversity of splice site strength
is crucial to correct cellular function, disruptions of these features can result in deleterious effects within
the gene and pathology within the cell. This thesis forms the foundation for further exploration into the
dynamics of splicing and the cells unique ability to utilise this mechanism in multiple ways.
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5.1.2 Splice junction reads are key to sensitive gene expression analysis
Splice junctions are a key concept and central to sensitive gene expression analysis. The power of detecting
splicing events with nucleotide precision has long been underestimated and overlooked. A striking realization
from this study is that exon expression is indeed a poor substitute for splice junction analysis. It is 2-3 fold
less sensitive than splicing statistics and cannot distinguish subtle splicing changes than can have a drastic
effect on the final transcript. Ideally, analysis should integrate expression and splicing in a meaningful way,
early attempts (such as Cuﬄinks [Trapnell et al., 2012] and MISO [Katz et al., 2010]) still miss much of
the most interesting non-canonical aspects of splicing. This thesis aims to contribute to the field of RNA
processing by demonstrating uses of alignment tools and standard bioinformatic techniques to exploit splice
junction reads.
5.1.3 Predicting damaging variation on splicing
MaxEnt [Yeo and Burge, 2004] has been the splice site scoring software used for more than ten years now.
This striking fact indicates that sequence clearly plays a substantial role in predicting RNA processing. This
tool has been used extensively in this thesis and is recognized as state of the art [Rosenberg et al., 2015].
Investigating variant effects on splicing remains largely unexplored. Several recent large studies [Xiong et al.,
2014; Rosenberg et al., 2015] have focused on evaluating alternative splicing by considering all variants in
and around these exons without directly answering the question: what effect do variants have on the central
splicing motif at a single site? This question was addressed here and shows that each splice site can be
evaluated independently and functional effects can be predicted and used to guide annotation. The question
that remains is how much of the predictive power of the recent tools (produced by aforementioned studies)
can be attributed to this. Expansion and inclusion of variants further from the splice site may in fact be
confounded with multiple other features and this needs to be systematically investigated.
5.1.4 The evolution of sequencing technology and its impact on splicing analysis
The acceleration of sequencing technology is at the epicentre of recent bioinformatics innovation. It has pro-
vided a unique opportunity for creative methods to be developed and has driven bioinformatics to utilise this
technology to the fullest. Although a massive improvement over hybridization-based techniques, sequencing
still suffers from common drawbacks such as batch effects and bias due to experimental protocol. Another
major remaining drawback is read length. Although improvements are continuously being made reads from
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the industry leader, Illumina, remain relatively short.
We are now looking ahead to the next (3rd) generation of sequencing by companies such as Pacific
Biosciences [Sakai et al., 2015] and Oxford Nanopore [Wei et al., 2016b]. These technologies promise much
longer reads at lower cost. This does not come without its complications and currently the estimated error
rate of Oxford Nanopore’s sequencer is a staggering 38% [Laver et al., 2015]. This can be mitigated to some
degree by high coverage sequencing (as these errors are random). As the technology improves however this
would likely be an excellent way to retrieve full transcripts, potentially showing knock-on effects of splicing
changes that are not recognizable now. Also, in the case of peculiar splicing patterns, this would once again
open a new world to identify and expand on non-canonical transcripts. One exciting application would be
to inspect the reciprocal splicing patterns identified in Chapter 3.
5.1.5 Data processing as a crucial skill in bioinformatics
Optimisation is an integral part of any successful genomics undertaking and is likely to become even more
paramount in future as data volumes continue to increase.
Genomics implies the mining of huge quantities of raw data. This creates unique challenges as
computational demands are diverse. The first consideration is hard drive space. In this study the mining
of 50 high depth RNA-seq samples (UKBEC brain data) required several terabytes of space and multiple
iterations of pipeline development over the entire study. Similarly, mining 426 GEUVADIS RNA-seq samples
(processed BAM files alone are over 2 terabytes) required several workarounds to enable efficient querying
of data within reasonable wall clock time. Secondly, both cpu and memory demands are high, for instance,
STAR sequence aligner requires at least 10 cores and 50 gigabytes of memory per sample to perform
optimally.
This brings us to the first level of optimisation which involves processing raw data; efficient read
mappers, highly optimized co-ordinate based tools (such as Bedtools) are essential to overcome basic ”heavy
lifting” of common data types. These steps often require effective use of a cluster compute system for initial
alignment, annotation and further coordinate-based manipulation.
However, in pipeline design the interaction of these tools often result in data bottlenecks that need
to be individually addressed. Another challenge, especially in exploratory science, is the need for specialised
and tailored algorithms and statistics. These are by nature suboptimal as they are often custom code written
in a high-level programming language.
Once initial testing has been completed a second step of optimisations must be applied to the pipeline.
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Generally this requires compartmentalising pipeline steps and efficient use of data structures. Compartmen-
talised processes can be optimised independently and parrallelised which greatly increase efficiency. Data
structures can allow for saving of complex, preprocessed data that can be recalled when needed. Although
this is seldom discussed in detail I do believe it is an essential (and often overlooked) skill to successfully
carrying out any genomics project.
5.1.6 Stepping forward, understanding splicing within the context of exon def-
inition
Exon definition is key to splice site recognition. It plays an essential role in recursive splicing, even when said
exon is not included in the final mRNA. A natural expansion of this study is to investigate this relationship
further, potentially through cryptic exons. Recently Ling et. al linked the presence of cryptic exons to
cellular deficiency of RNA binding protein TDP-43 [Ling et al., 2015]. TDP-43 silences and blocks the
expression of these spurious exons but in its absence their expression can disrupt mRNA within neurons
resulting in severe pathology. Further work could include investigation of RNA binding factor knockdown
experiments (currently available on ENCODE) and their impact on recursive and cryptic exon expression.
A natural extension of the current work on splicing variation (in lieu of cryptic exons) is to start
modelling variant changes within introns to determine if these locations are likely to form novel splice sites.
Secondly, scanning introns for strong splice motifs (both 5’ and 3’) can predict locations of ’viable’ cryptic
exons. Ideally this should take into account RBP data (i.e. TDP-43) as this will help annotate sites.
Splicing remains an intricate process. The sheer elegance of a system that functions so efficiently
and yet remains robust to even large sequence change is both impressive and daunting. There are clearly still
many secrets and hidden mechanisms to the operation of this system. In order to improve our knowledge
of splicing and hence, factors that can disrupt its function, we must integrate data. In this study the
integration of variant and expression data is a powerful first step to understanding the effect of variation on
transcription. It is clear there is much more than can be explained by polymorphism alone and I believe to
design an effective tool to predict splicing function we will need to integrate data from other sources such as
histone modification, Dnase hypersensitivity, RNA binding protein density etc. For example, it is clear that
H3k36me3 will have a pronounced effect on recognition of splice motifs. In cases with high densities of this
mark I would need more drastic sequence change to see effects and vice versa.
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5.2 Medical Implications
Whole Exome sequencing has been a core part of the expansion of sequencing technology and its impact on
clinical genetics. The promise of exome sequencing comes from the prediction that 85% of the disease-causing
mutations are located in coding and functional regions of the genome [Botstein and Risch, 2003; Majewski
et al., 2011]. This however, translated into a 20% causal variant discovery in cohorts [Yang et al., 2013],
which indicates variants are either being missed or much deleterious variation lies outside of the exome.
While this study aims to improve the former (through enhanced variant splicing prediction), the
latter has motivated large-scale whole genome sequencing projects such as 100,000 Genomes Project run
by Genomics England Ltd. This will provide a huge improvement to splicing-related features such as deep-
intronic variation which could create cryptic exons and disrupt branchpoints. A further advantage would be
detection of variation at recursive splice sites that could contribute significantly to brain-related pathology.
Change here is likely to have a striking effect as the importance of strong splice signals is exemplified by the
strong species conservation and lack of transcription histone marks.
The improved understanding of splice site related variation can highlight potentially damaging poly-
morphism. These variants can now be classified as having either negative or positive effect on splicing; a
negative impact on canonical splice sites is well documented as disease causing but the preferential use of an
alternative exon or creation of a new splice site (either exonic or intronic) has not been explored extensively
although there are documented cases where this variation is pathogenic [Webb et al., 2012].
Certain branchpoint mutations are disease causing [Stenson et al., 2003], however, the ability to
predict branchpoint mutation from sequence remains elusive. The degenerate nature of this feature makes
it difficult to characterise, largely due to the lack of known sites and lack of variant information at these
positions (as they often fall outside exome capture). Whole genome sequencing will greatly help with the
latter but primary identification of these sites will still be essential to successfully modelling this interaction.
Factors such as histone modifications and chromatin state may play a key role in how specific this motif
needs to be and will need to be studied further.
Circular RNA have great potential as influential, non-coding RNA. Their enrichment in neurons
(particularly synaptomes) hints at their importance in neuronal function. circRNA also have a future as
disease biomarkers as they are enriched in various easily accessible tissues. In order to use them as biomarkers
their detection must be as sensitive and robust as possible and this work will contribute to the methods
applicable to accurate quantification from RNA-seq data. This in conjunction with circRNA enrichment
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techniques such as RNase treatment (to degrade linear RNA) is essential for accurate quantification.
Another unexplored clinical application is to improve understanding of how cancer deregulates cel-
lular machinery. One example would be the androgen receptor gene which is crucial in prostate cancer. In
2008 it was shown that cryptic exons within these genes signify the presence of cancer [Scott M. Dehm, 2008;
Hu et al., 2009], these splice isoforms have recently been further expanded [Lu and Luo, 2013; Krause et al.,
2014]. The ability to accurately predict potential cryptic exon presence according to mutation of splice sites
could be highly advantageous in identification of causal mutation in cancer.
5.3 Further thoughts and future work
5.3.1 Recursive splicing as a genomic mechanism to control promoter usage
The elucidation of recursive splicing, a process whereby an initial splicing step reconstitutes a 5’ splice site,
allowing for exclusion of a poison exon, will no doubt yield novel deleterious mutations with significant
impact on neuronal function. The occurrence of RS in genes with long (150kb+) introns are significantly
enriched in the brain and carry characteristic transcription-related histone marks signatures. Taken together,
recursive splicing opens the discussion on another level of transcriptional control using the intrinsic power
of exon definition and splice site strength to determine exon inclusion.
The use of co-transcriptional patterns to identify splicing (and hence RS) is only effective in long
introns. In order to identify gradients in the data you have to bin read counts by at least one kilobase.
Other effects such as expression of the gene, number of samples and heterogeneity between brain regions
substantially increase noise levels. For these reasons the co-transcriptional pattern is not detectable in shorter
introns.
Another concern is the definition of recursive exon. This is partially defined by the lack of an
annotated exon. However, recent improvements in annotation show inclusion of some recursive exons as
”alternate” exons. This will require further careful definition of what constitutes a recursive exon. Rather
than searching for cases outside of known exons the focus could be shifted to whether the cell can effectively
use the head-to-head splice sites in different situations.
The further exploration of RS in shorter genes and other tissues is a logical next step. This will
require algorithmic improvements relying heavily on splice junctions and superior sample numbers to identify
true positive cases. A natural extension would also focus on analysis of splicesosomal RBPs and their impact
on these sites. This will likely expand situations in which this mechanism may fulfil different roles.
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5.3.2 Circular RNA as novel, brain enriched RNA molecules
Circular RNA has recently received a great deal of attention. These non-coding RNA remain largely shrouded
in mystery. The majority have no reported function, they are independently regulated from their linear
isoforms, are significantly enriched in brain, detected in saliva, blood and exosomes. Their characterization
depends on their backsplice junction. Here I create a sensitive algorithm combining two well documented
analysis procedures to maximise and discover large numbers of circRNA within the human brain.
Although circRNA studies have been done in fetal brain and differentiated neuronal cells [Venø
et al., 2015; Rybak-Wolf et al., 2015], this is the first, thorough documentation of circRNA in a large human
brain cohort. This would explain the large increase in novel circRNA isoforms.
A novel algorithm was created to examine a subclass of backsplice junctions between proximal, highly
homologous gene pairs. Findings indicate potential reciprocal transplicing/backsplicing between transcripts.
When looking at highly similar genes the attempt to distinguish bona-fide backsplicing from standard splicing
is very challenging. Initial results indicate this could be a novel biological mechanism but without laboratory
validation it remains inconclusive.
Quantifying circRNA is notoriously challenging. Relying solely on the backsplice junction results in
a significant loss of reads (due to the minimum overhang requirement). This can be somewhat circumvented
by creating artificial scaffolds to allow for read recovery, although this also increases redundancy within the
search space reducing unique mapping reads. Many of these initially identified backsplice junctions appear
to be very lowly expressed, it is unclear if these are noise or low-level biological variation. Currently there
is no standard on how to determine expression of circRNA, as such I focus on highly expressed examples.
Identification of transplicing/backsplicing between genes will remain controversial until significant
laboratory evidence is available. However, this effect can be further explored in different organisms that
many share the same gene structures such as mouse and zebrafish. Due to the difficulty in obtaining high
quality RNA from human brain, a comprehensive study of such gene pairs could be undertaken in more
easily accessible tissue or within cell lines.
The field of circRNA is still developing rapidly. Future studies will surely provide hints to explore
in more detail. One future goal would be to explore transplicing/backsplicing across the transcriptome,
possibly in combination with Hi-C and CTCF CHIP-seq data (ideally in human brain), to determine whether
chromosomal structure plays a role in their formation.
Currently circRNA are being investigated as potential biomarkers. Taking the opportunity to mine
the wealth of publicly available data could reveal further disease markers. This could be particularly inter-
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esting in cases where linear isoforms do not show any differential expression, as in the case study of BPTF
in Bipolar disorder.
5.3.3 Analysis of splicing variants and their impact on transcription
Large exome consortia provide a unique opportunity to use variant frequencies in novel ways. I outline
a method to create a nucleotide resolution map of invariant positions within genomic features. I could
then explore the effect of these variants on splicing efficiency by integrating gene expression RNA-seq with
whole exome sequencing. In order to do this an estimate of the effect of the variant on the splice site was
created. This score captures a significant proportion of variance between variants and non-variants. The
effect of variation on splicing efficiency can be either positive or negative, both are potentially deleterious to
canonical expression. Surprisingly, the majority of variation has no significant effect on splicing indicating
the robust nature of cellular splicing.
Integration of RNA-seq and whole exome is still in its infancy, as such this study remains statistically
underpowered. Correlations are drawn from small (20-60) numbers of cases (after filtering) which show
significant variant effects. The inability to accurately identify true negative cases is a central concern.
Generally, the lack of expression of genes and inadequate sequencing depth increases variability leading
to high levels of ”missing-ness”. Although it is clear the variant score captures a component of sequence
variation it remains only part of the story.
Ideally future work would require larger RNA-seq and Exome consortia. With the increase in samples
it will be possible to accurately classify variant effects, particularly cases with no effect (or marginal impact).
This could also allow potential integration of cell specific epigenetic factors (histone marks, methylation)
and RNA binding factors. The expansion of variants of interest deeper into splice sites would also be an
important step however this will require careful annotation of variants and their predicted overlap with other
exonic/intronic features.
5.4 Final thoughts
Together, this thesis hints at the enormous potential of next generation sequencing to propel our understand-
ing of cellular biology through its sensitivity, re-usability and scale. Central to this is the use of publicly
available resources which are becoming increasingly abundant as time passes. It is my opinion that in the
near future all cellular studies will benefit directly from the wealth of sequence data, guiding experimental
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work and testing hypotheses before entering the lab. Soon computational approaches will not stand sep-
arately but be an essential step in every biological study informing experimental design as much as final
validation.
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Appendix
Sample ID Sample name Population Unmapped reads Total reads Uniquely mapped reads
HG00096.1.M1111246 HG00096 GBR 749198 54512330 52490638
HG00097.7.M1202192 HG00097 GBR 2028887 87882216 83657715
HG00099.1.M1202096 HG00099 GBR 689457 42279782 40623431
HG00099.5.M1201313 HG00099 GBR 5281077 79375834 72103090
HG00100.2.M1112158 HG00100 GBR 799233 44683676 42664671
HG00101.1.M1111244 HG00101 GBR 750663 46516462 44750969
HG00102.3.M1202028 HG00102 GBR 947358 42245278 40198976
HG00103.4.M1202083 HG00103 GBR 655952 51371940 49449377
HG00104.1.M1111245 HG00104 GBR 4118192 53789606 48426398
HG00105.1.M1202097 HG00105 GBR 812991 45109250 43153711
HG00105.3.M1202236 HG00105 GBR 3423341 90984450 85252445
HG00106.4.M1202085 HG00106 GBR 642043 55590222 53531102
HG00108.7.M1202192 HG00108 GBR 2191175 81096644 76656384
HG00109.1.M1202094 HG00109 GBR 914189 40426858 38572948
HG00109.3.M1202025 HG00109 GBR 1452343 35339058 32957736
HG00110.2.M1201312 HG00110 GBR 1705761 77273036 73513206
HG00111.1.M1202098 HG00111 GBR 949149 44447978 42327537
HG00111.2.M1112154 HG00111 GBR 1018901 70129972 67086970
HG00112.6.M1201192 HG00112 GBR 781275 51683556 49559920
HG00114.1.M1202093 HG00114 GBR 1036321 53995672 51646881
HG00114.6.M1202171 HG00114 GBR 503591 40109798 38598295
HG00115.6.M1201191 HG00115 GBR 750221 54454188 52356964
HG00116.2.M1201311 HG00116 GBR 1084765 55830456 53239542
HG00117.1.M1111242 HG00117 GBR 2796084 109095664 103900574
HG00117.1.M1202091 HG00117 GBR 1484537 60719248 57771650
HG00117.2.M1112164 HG00117 GBR 819415 51926286 49779807
HG00117.3.M1202026 HG00117 GBR 388899 33075792 31796173
HG00117.4.M1202084 HG00117 GBR 465394 47575136 45949471
HG00117.5.M1201313 HG00117 GBR 648931 61861444 59688047
HG00117.6.M1202171 HG00117 GBR 623404 46317542 44521685
HG00117.7.M1202194 HG00117 GBR 1199228 62145486 59421064
HG00118.4.M1202085 HG00118 GBR 549439 57526386 55538725
HG00119.1.M1202093 HG00119 GBR 611765 39611928 38076495
HG00119.2.M1112166 HG00119 GBR 824561 63762212 61365974
HG00120.3.M1202022 HG00120 GBR 768364 27921432 26454217
HG00121.1.M1111247 HG00121 GBR 555473 41264264 39737825
HG00122.6.M1201191 HG00122 GBR 962321 60682448 58204913
HG00123.4.M1202087 HG00123 GBR 578385 62040106 59807299
HG00124.3.M1202237 HG00124 GBR 1139818 61028462 58346858
HG00125.1.M1111246 HG00125 GBR 3144291 57426696 52967279
HG00126.1.M1111248 HG00126 GBR 1219309 73205592 70182514
HG00127.1.M1111242 HG00127 GBR 1047538 73589032 70884728
HG00128.1.M1111246 HG00128 GBR 1710232 56537920 53499918
HG00129.4.M1202088 HG00129 GBR 668430 48154050 46249311
HG00130.5.M1201317 HG00130 GBR 667930 63452554 61074197
HG00131.1.M1202098 HG00131 GBR 621485 29379134 28095616
HG00131.2.M1112155 HG00131 GBR 806992 59497434 57238075
HG00132.2.M1112154 HG00132 GBR 928224 74637674 71738664
HG00133.1.M1202095 HG00133 GBR 1023518 50696358 48351582
HG00133.2.M1112162 HG00133 GBR 893968 54079816 51726909
HG00134.1.M1202093 HG00134 GBR 596630 32031216 30677000
HG00134.6.M1201196 HG00134 GBR 1114744 79709308 76686408
HG00135.3.M1202028 HG00135 GBR 544287 29310864 28075438
HG00136.4.M1202087 HG00136 GBR 651540 54619716 52584455
HG00137.1.M1202096 HG00137 GBR 1019638 44211128 42094324
HG00137.6.M1202171 HG00137 GBR 791046 48468364 46399910
HG00138.1.M1202092 HG00138 GBR 1401091 55049138 52192193
HG00138.5.M1201315 HG00138 GBR 805132 58861586 56397945
HG00139.7.M1202191 HG00139 GBR 2137325 85762042 81731056
HG00141.5.M1201313 HG00141 GBR 631995 73743558 71482529
HG00142.1.M1202097 HG00142 GBR 707630 38930764 37307190
HG00142.4.M1202086 HG00142 GBR 559264 50277322 48460421
HG00143.1.M1202097 HG00143 GBR 554721 26193256 24973852
HG00143.7.M1202192 HG00143 GBR 1457224 57775998 54880875
HG00145.6.M1201191 HG00145 GBR 2278481 59365444 55577082
HG00146.2.M1112161 HG00146 GBR 847112 57005198 54798442
HG00148.3.M1202026 HG00148 GBR 1748793 41614086 38816013
HG00149.1.M1111246 HG00149 GBR 1395132 61742046 59082919
HG00150.4.M1202087 HG00150 GBR 582078 58932186 56880604
HG00151.3.M1202024 HG00151 GBR 424264 30487154 29208383
HG00152.7.M1202193 HG00152 GBR 2347452 110582784 105688428
HG00154.5.M1201317 HG00154 GBR 742094 65141032 62724775
HG00155.1.M1111242 HG00155 GBR 1270900 42583390 40400356
HG00156.4.M1202081 HG00156 GBR 819157 48969934 46900145
HG00157.5.M1201313 HG00157 GBR 848011 79621746 76740292
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HG00158.1.M1111248 HG00158 GBR 3732903 60848970 55738921
HG00159.7.M1202196 HG00159 GBR 1195056 69646436 66524018
HG00160.3.M1202021 HG00160 GBR 414819 32851462 31577762
HG00171.3.M1202022 HG00171 FIN 767933 29521242 27908203
HG00173.3.M1202021 HG00173 FIN 2704658 34700564 31062238
HG00174.4.M1202083 HG00174 FIN 683879 55215260 53082274
HG00176.4.M1202082 HG00176 FIN 578127 49661418 47813290
HG00177.4.M1202088 HG00177 FIN 1142310 55116370 52477167
HG00178.4.M1202088 HG00178 FIN 843399 58419390 56016787
HG00179.1.M1111248 HG00179 FIN 801585 49588788 47487851
HG00180.1.M1111248 HG00180 FIN 1158707 65930310 63149406
HG00181.4.M1202084 HG00181 FIN 601315 49443668 47756284
HG00182.1.M1111244 HG00182 FIN 1112763 53296184 50902769
HG00183.1.M1202094 HG00183 FIN 583462 28937892 27687247
HG00183.5.M1201315 HG00183 FIN 727991 60884944 58555422
HG00185.1.M1111245 HG00185 FIN 1150500 61469182 58971505
HG00186.3.M1202025 HG00186 FIN 390786 30752930 29570016
HG00187.1.M1202092 HG00187 FIN 1543424 75204862 71764523
HG00188.1.M1111243 HG00188 FIN 1385905 73841290 70514248
HG00189.1.M1111245 HG00189 FIN 807370 49911214 47922584
HG00231.2.M1112162 HG00231 GBR 925781 57951478 55419089
HG00232.7.M1202193 HG00232 GBR 810358 37284710 35533448
HG00233.2.M1112158 HG00233 GBR 1446518 65033070 61876887
HG00234.7.M1202194 HG00234 GBR 1598824 98890090 94829074
HG00235.1.M1111241 HG00235 GBR 900107 46554128 44570396
HG00236.5.M1201315 HG00236 GBR 753366 69096566 66719637
HG00237.4.M1202081 HG00237 GBR 903467 94738518 91369321
HG00238.5.M1201315 HG00238 GBR 616380 60169628 58138986
HG00239.7.M1202194 HG00239 GBR 1496057 78605382 75145936
HG00240.2.M1112155 HG00240 GBR 1166380 74518950 71538864
HG00242.3.M1202027 HG00242 GBR 501653 46773516 45122738
HG00243.4.M1202082 HG00243 GBR 457465 53934380 52209855
HG00244.5.M1201317 HG00244 GBR 738074 66702862 64436484
HG00245.4.M1202086 HG00245 GBR 496618 57340796 55497878
HG00246.7.M1202194 HG00246 GBR 1242031 67380572 64462349
HG00247.3.M1202021 HG00247 GBR 539055 51939320 50131559
HG00249.3.M1202024 HG00249 GBR 283753 30945204 29841964
HG00250.1.M1111244 HG00250 GBR 763705 45170548 43394933
HG00251.2.M1112168 HG00251 GBR 1218262 64643794 61693659
HG00252.1.M1111245 HG00252 GBR 968620 52522222 50371724
HG00253.5.M1201317 HG00253 GBR 627597 69198938 66754512
HG00255.2.M1112161 HG00255 GBR 852858 61462332 58977565
HG00256.2.M1112157 HG00256 GBR 1487950 70493240 67121379
HG00257.4.M1202085 HG00257 GBR 451909 48474192 46774497
HG00258.1.M1111246 HG00258 GBR 1142808 58644934 56167007
HG00259.5.M1201313 HG00259 GBR 1040636 106082286 102542292
HG00260.5.M1201317 HG00260 GBR 664703 64797710 62620767
HG00261.6.M1201192 HG00261 GBR 724744 58285418 56115725
HG00262.2.M1112158 HG00262 GBR 1371748 75224892 71855416
HG00263.6.M1201193 HG00263 GBR 1008256 60348520 57757935
HG00264.6.M1201195 HG00264 GBR 644394 44161314 42369179
HG00265.2.M1112154 HG00265 GBR 847342 58321994 55837532
HG00266.6.M1201193 HG00266 FIN 1347520 68981404 65436476
HG00267.4.M1202086 HG00267 FIN 648564 54821964 52754538
HG00268.5.M1201313 HG00268 FIN 665061 59784120 57530749
HG00269.2.M1112167 HG00269 FIN 845209 52600642 50217142
HG00271.2.M1112157 HG00271 FIN 1884590 79845062 75823094
HG00272.7.M1202197 HG00272 FIN 1309631 57956092 55126879
HG00273.3.M1202027 HG00273 FIN 385439 32950518 31687519
HG00274.6.M1201191 HG00274 FIN 1313982 63913242 60900413
HG00275.4.M1202088 HG00275 FIN 469184 50226662 48580170
HG00276.2.M1112158 HG00276 FIN 1734072 79210664 75344869
HG00277.1.M1202095 HG00277 FIN 1260583 26420228 24564578
HG00277.3.M1202026 HG00277 FIN 682802 44028638 42190950
HG00278.1.M1111245 HG00278 FIN 1045086 47568268 45197476
HG00280.1.M1111246 HG00280 FIN 2732752 59825588 55668237
HG00281.1.M1111243 HG00281 FIN 1387406 63903074 60880534
HG00282.2.M1112166 HG00282 FIN 1011084 58880784 56249613
HG00284.1.M1111246 HG00284 FIN 940898 67342242 64882358
HG00285.3.M1202025 HG00285 FIN 725484 52050380 50058220
HG00306.1.M1111241 HG00306 FIN 1597320 48143640 45431834
HG00308.3.M1202023 HG00308 FIN 435523 34143244 32902914
HG00309.7.M1202197 HG00309 FIN 2087048 114200140 109280328
HG00310.4.M1202083 HG00310 FIN 900242 61438062 59050194
HG00311.4.M1202086 HG00311 FIN 578451 51388626 49500197
HG00312.7.M1202196 HG00312 FIN 2172850 106376808 101163286
HG00313.1.M1202092 HG00313 FIN 859508 29162420 27632915
HG00313.2.M1112166 HG00313 FIN 676118 52152128 50202199
HG00315.1.M1202095 HG00315 FIN 872817 21958446 20567151
HG00315.2.M1112155 HG00315 FIN 1403657 73003930 69713221
HG00319.4.M1202087 HG00319 FIN 730102 51673018 49602297
HG00320.1.M1111241 HG00320 FIN 1351027 61802814 59069283
HG00321.1.M1202096 HG00321 FIN 446891 20675140 19755084
HG00321.2.M1112162 HG00321 FIN 918483 63143982 60698266
HG00323.1.M1111244 HG00323 FIN 855723 43631078 41834293
HG00324.1.M1111242 HG00324 FIN 1071064 65534436 62795559
HG00325.1.M1202093 HG00325 FIN 599670 24099402 22913549
HG00325.5.M1201311 HG00325 FIN 969883 71143378 68333523
HG00326.1.M1111247 HG00326 FIN 1449980 65268886 62280910
HG00327.3.M1202024 HG00327 FIN 605889 38607132 37016880
HG00328.1.M1202092 HG00328 FIN 969779 31232236 29480799
HG00328.2.M1112154 HG00328 FIN 1198119 74850434 71622833
HG00329.5.M1201313 HG00329 FIN 3697469 47072576 42215543
HG00330.1.M1202092 HG00330 FIN 1250709 59256250 56616506
HG00331.7.M1202198 HG00331 FIN 2082837 73600510 69501694
HG00332.6.M1202171 HG00332 FIN 912096 52284106 50044943
HG00334.2.M1112165 HG00334 FIN 837351 53791954 51398319
HG00335.2.M1112165 HG00335 FIN 978286 59734656 57271720
HG00336.1.M1202092 HG00336 FIN 1248447 54234874 51707478
HG00337.5.M1201315 HG00337 FIN 1091263 49967898 47508611
HG00338.1.M1202093 HG00338 FIN 966212 26710008 25101274
HG00338.2.M1112158 HG00338 FIN 1431693 91968236 88104947
HG00339.4.M1202081 HG00339 FIN 933999 53479508 51229442
141
HG00341.2.M1112167 HG00341 FIN 832831 58928796 56217599
HG00342.1.M1111241 HG00342 FIN 1531496 69581996 66411774
HG00343.1.M1111245 HG00343 FIN 1365436 74687016 71577271
HG00344.4.M1202082 HG00344 FIN 1007333 53414964 51060988
HG00345.1.M1202091 HG00345 FIN 7296921 57141914 48671545
HG00346.2.M1201311 HG00346 FIN 1538039 70543656 67191831
HG00349.1.M1202094 HG00349 FIN 1064246 37551542 35572251
HG00349.4.M1202084 HG00349 FIN 726786 52240932 50136711
HG00350.3.M1202023 HG00350 FIN 699656 31012760 29552643
HG00351.6.M1201195 HG00351 FIN 723496 39398264 37608021
HG00353.1.M1111246 HG00353 FIN 2120813 58932298 55142603
HG00355.1.M1111248 HG00355 FIN 1024916 61594360 59127694
HG00355.1.M1202091 HG00355 FIN 1208434 53652850 51202171
HG00355.2.M1112156 HG00355 FIN 1210343 80597632 77360556
HG00355.3.M1202026 HG00355 FIN 751249 39555882 37800017
HG00355.4.M1202083 HG00355 FIN 910434 51909912 49809926
HG00355.5.M1201313 HG00355 FIN 778771 62245906 59973443
HG00355.6.M1201191 HG00355 FIN 1186029 60251304 57617719
HG00355.7.M1202196 HG00355 FIN 1168830 58274530 55694138
HG00356.2.M1112156 HG00356 FIN 1736897 77277652 73380693
HG00358.5.M1201315 HG00358 FIN 2390431 60759656 56909880
HG00359.1.M1111246 HG00359 FIN 1262468 62088610 59550399
HG00360.3.M1202028 HG00360 FIN 790509 45173626 43180239
HG00361.7.M1202195 HG00361 FIN 1571896 72096474 68713859
HG00362.3.M1202022 HG00362 FIN 1180230 49530778 47156283
HG00364.2.M1112158 HG00364 FIN 1601088 71431192 67917815
HG00365.7.M1202195 HG00365 FIN 2464643 117130594 111894206
HG00366.4.M1202081 HG00366 FIN 946746 60585410 58045650
HG00367.2.M1201311 HG00367 FIN 1407901 72678706 69209504
HG00369.5.M1201311 HG00369 FIN 836554 66352376 63792095
HG00371.1.M1111243 HG00371 FIN 1036302 52529480 50335015
HG00372.4.M1202083 HG00372 FIN 617389 54274048 52404123
HG00373.2.M1112156 HG00373 FIN 1781698 78237278 74479259
HG00375.1.M1202092 HG00375 FIN 759917 42326842 40503837
HG00375.4.M1202084 HG00375 FIN 583352 59263738 57107128
HG00376.2.M1112161 HG00376 FIN 917245 61387898 59065023
HG00377.1.M1202096 HG00377 FIN 718624 30247010 28726971
HG00377.2.M1201312 HG00377 FIN 1495105 70377550 66855499
HG00378.1.M1202095 HG00378 FIN 1012921 45581642 43489987
HG00378.5.M1201315 HG00378 FIN 880313 68749508 66143028
HG00379.5.M1201313 HG00379 FIN 722772 67850492 65401089
HG00380.3.M1202028 HG00380 FIN 732489 41777474 39847496
HG00381.3.M1202027 HG00381 FIN 1146762 24796800 22981610
HG00382.4.M1202084 HG00382 FIN 456913 52516778 50830374
HG00383.1.M1111241 HG00383 FIN 1330294 67601226 64675410
HG00384.2.M1112164 HG00384 FIN 1465240 82130466 78546332
HG01334.7.M1202198 HG01334 GBR 1668599 83092828 79571096
HG01789.6.M1201191 HG01789 GBR 961017 51020536 48737578
HG01790.3.M1202023 HG01790 GBR 908438 25332966 23880257
HG01791.2.M1112165 HG01791 GBR 754652 64087010 61858818
HG02215.1.M1111244 HG02215 GBR 1042369 61675318 59182056
NA06984.1.M1111244 NA06984 CEU 2541057 44272764 40664227
NA06985.1.M1111247 NA06985 CEU 1089875 66527668 63524029
NA06986.1.M1111247 NA06986 CEU 1027285 53649706 51220829
NA06986.1.M1202091 NA06986 CEU 1301403 52243706 49594840
NA06986.2.M1112154 NA06986 CEU 916428 66099122 63278699
NA06986.3.M1202021 NA06986 CEU 548421 39459940 37813454
NA06986.4.M1202081 NA06986 CEU 799298 49434086 47330542
NA06986.5.M1201315 NA06986 CEU 610584 58366372 56100684
NA06986.6.M1201194 NA06986 CEU 967160 51258606 48911674
NA06986.7.M1202196 NA06986 CEU 1301654 67915336 64760467
NA06989.3.M1202027 NA06989 CEU 467594 41445550 39910934
NA06994.1.M1202094 NA06994 CEU 514164 25284160 24120407
NA06994.2.M1112157 NA06994 CEU 1693698 75751284 72022673
NA07000.1.M1202092 NA07000 CEU 1617287 54424158 51416839
NA07037.1.M1202093 NA07037 CEU 678159 32308424 30870288
NA07037.6.M1201194 NA07037 CEU 796225 52053342 49969416
NA07048.1.M1202098 NA07048 CEU 768296 32374402 30842352
NA07048.6.M1201196 NA07048 CEU 836344 46896124 44949409
NA07051.1.M1202096 NA07051 CEU 607897 29483640 28024209
NA07051.5.M1201311 NA07051 CEU 2157531 60115850 56262522
NA07056.1.M1111243 NA07056 CEU 1036383 57833950 55235228
NA07346.1.M1202094 NA07346 CEU 564687 24245598 23051670
NA07346.2.M1112157 NA07346 CEU 1433980 66517758 63186357
NA07347.1.M1202097 NA07347 CEU 7352918 37148508 29128350
NA07347.7.M1202193 NA07347 CEU 1661568 67598810 64421511
NA07357.1.M1202098 NA07357 CEU 699607 30542664 29058994
NA07357.2.M1112165 NA07357 CEU 760801 52906598 50696419
NA10847.1.M1202097 NA10847 CEU 948180 31836926 30045031
NA10847.4.M1202084 NA10847 CEU 699053 59587646 57192390
NA10851.1.M1202091 NA10851 CEU 738868 29681638 28164061
NA10851.4.M1202081 NA10851 CEU 657186 49702518 47689333
NA11829.1.M1202097 NA11829 CEU 536534 32059754 30596880
NA11829.6.M1202171 NA11829 CEU 690659 39104832 37226370
NA11830.1.M1202096 NA11830 CEU 881532 40386354 38492170
NA11830.3.M1202024 NA11830 CEU 801426 48715912 46549298
NA11831.1.M1202095 NA11831 CEU 7146741 45612002 37511561
NA11831.7.M1202192 NA11831 CEU 1828048 86943042 82912252
NA11832.1.M1202097 NA11832 CEU 747346 30181644 28679322
NA11832.2.M1201312 NA11832 CEU 1613840 70076616 66589784
NA11840.1.M1202094 NA11840 CEU 701856 24732602 23392390
NA11840.6.M1201195 NA11840 CEU 1139182 53223308 50628261
NA11843.1.M1202095 NA11843 CEU 813859 33349504 31638506
NA11843.4.M1202086 NA11843 CEU 633716 57414544 55146924
NA11881.1.M1111245 NA11881 CEU 1282675 67230954 64247985
NA11892.1.M1111242 NA11892 CEU 978546 48985566 46700450
NA11893.1.M1202094 NA11893 CEU 553256 27479310 26236769
NA11893.7.M1202193 NA11893 CEU 1472326 85643402 81961159
NA11894.1.M1202094 NA11894 CEU 429247 23315654 22292244
NA11894.2.M1112154 NA11894 CEU 1049171 65162588 62282935
NA11918.1.M1111243 NA11918 CEU 829342 48647220 46585815
NA11920.2.M1201311 NA11920 CEU 1672480 62990540 59569087
NA11930.1.M1202098 NA11930 CEU 7371097 42003756 33775440
142
NA11930.3.M1202028 NA11930 CEU 608595 42256998 40577631
NA11931.1.M1111248 NA11931 CEU 1237330 51250304 48539575
NA11992.1.M1202096 NA11992 CEU 1261294 39641152 37310298
NA11992.6.M1201195 NA11992 CEU 755932 45563128 43559943
NA11993.2.M1112164 NA11993 CEU 1012255 61487248 58799152
NA11994.1.M1202093 NA11994 CEU 808570 39562466 37777612
NA11994.2.M1112167 NA11994 CEU 1164480 84995764 81616942
NA11995.1.M1202095 NA11995 CEU 471356 28791980 27573718
NA11995.7.M1202195 NA11995 CEU 1234135 54004124 51350376
NA12004.1.M1202098 NA12004 CEU 650258 31096898 29635147
NA12004.4.M1202085 NA12004 CEU 2436741 47186642 43560691
NA12005.4.M1202081 NA12005 CEU 541497 55113076 53089896
NA12006.1.M1202095 NA12006 CEU 729594 32191986 30638099
NA12006.5.M1201311 NA12006 CEU 682176 62427064 60033862
NA12043.1.M1202096 NA12043 CEU 813363 37878564 36126962
NA12043.2.M1201277 NA12043 CEU 752794 58858732 56470892
NA12044.4.M1202088 NA12044 CEU 593497 60289002 57971799
NA12045.1.M1202093 NA12045 CEU 784194 32216162 30655830
NA12045.3.M1202023 NA12045 CEU 765840 37476622 35822170
NA12058.1.M1202097 NA12058 CEU 834375 36768270 35068219
NA12058.5.M1201317 NA12058 CEU 628035 63238230 61107459
NA12144.1.M1202093 NA12144 CEU 7524036 37811646 29558208
NA12144.4.M1202081 NA12144 CEU 1094169 63724788 61059790
NA12154.1.M1202093 NA12154 CEU 782529 31569258 30048739
NA12154.5.M1201313 NA12154 CEU 684747 53236140 51226581
NA12155.1.M1202095 NA12155 CEU 797683 36593020 34917613
NA12155.4.M1202088 NA12155 CEU 638052 44337836 42565076
NA12156.1.M1202097 NA12156 CEU 1220027 43855948 41510158
NA12156.4.M1202087 NA12156 CEU 944156 58845272 56345779
NA12234.1.M1202098 NA12234 CEU 505938 33583232 32187333
NA12234.7.M1202196 NA12234 CEU 1136419 68921256 65977024
NA12249.1.M1202091 NA12249 CEU 1215677 57229250 54544449
NA12272.1.M1202095 NA12272 CEU 543693 29563466 28285278
NA12272.3.M1202025 NA12272 CEU 954314 37308646 35379224
NA12273.1.M1111244 NA12273 CEU 1930460 64977326 61362746
NA12275.1.M1202094 NA12275 CEU 986574 24314976 22705231
NA12275.7.M1202195 NA12275 CEU 1787048 62722820 59266182
NA12282.1.M1202096 NA12282 CEU 470209 25766822 24559102
NA12282.3.M1202027 NA12282 CEU 405171 33102104 31675698
NA12283.1.M1202094 NA12283 CEU 727579 22534706 21246734
NA12283.2.M1112165 NA12283 CEU 1009106 52007306 49652716
NA12286.1.M1202096 NA12286 CEU 860663 26830438 25258877
NA12286.2.M1112161 NA12286 CEU 1495991 60585758 57375686
NA12287.1.M1202096 NA12287 CEU 943415 26671348 25123621
NA12287.3.M1202023 NA12287 CEU 463513 34070922 32852090
NA12340.1.M1202093 NA12340 CEU 962514 31851306 30019957
NA12340.5.M1201317 NA12340 CEU 723880 61284172 58771792
NA12341.1.M1111245 NA12341 CEU 1422818 62894450 59837245
NA12342.1.M1111245 NA12342 CEU 5038486 58045918 51613452
NA12347.1.M1111247 NA12347 CEU 1500457 63877988 60733387
NA12348.1.M1202093 NA12348 CEU 1006490 22379028 20842844
NA12348.3.M1202026 NA12348 CEU 675997 28331306 26904703
NA12383.1.M1111243 NA12383 CEU 1005674 55083068 52672640
NA12399.1.M1202094 NA12399 CEU 1375890 29453468 27322198
NA12399.7.M1202191 NA12399 CEU 4650459 146767882 138323147
NA12400.1.M1202097 NA12400 CEU 1159393 26369656 24532465
NA12400.2.M1112162 NA12400 CEU 1140767 50613994 48016199
NA12413.1.M1202096 NA12413 CEU 686352 22990910 21725011
NA12413.2.M1112156 NA12413 CEU 1693506 75916544 72099679
NA12489.1.M1111242 NA12489 CEU 4614731 67642678 61358191
NA12546.1.M1202096 NA12546 CEU 7862860 28236186 19866661
NA12546.3.M1202024 NA12546 CEU 1024630 37335380 35357510
NA12716.1.M1202095 NA12716 CEU 1391067 42124014 39715743
NA12716.7.M1202196 NA12716 CEU 4032998 157239402 148843563
NA12717.1.M1111243 NA12717 CEU 1321021 56071888 53230370
NA12718.1.M1111247 NA12718 CEU 1555797 69986762 66729621
NA12749.1.M1111242 NA12749 CEU 982205 47629086 45588581
NA12750.1.M1202097 NA12750 CEU 878457 25668122 24165460
NA12750.2.M1112162 NA12750 CEU 741336 56406698 54097915
NA12751.1.M1202096 NA12751 CEU 837239 30193600 28628916
NA12751.2.M1112158 NA12751 CEU 1718540 73191558 69507256
NA12760.1.M1202095 NA12760 CEU 656358 27284570 25952227
NA12760.3.M1202023 NA12760 CEU 376643 29995518 28894333
NA12761.1.M1202093 NA12761 CEU 708131 25801218 24493385
NA12761.6.M1201192 NA12761 CEU 925005 59918966 57505186
NA12762.1.M1202095 NA12762 CEU 2222100 36597736 33558082
NA12762.4.M1202083 NA12762 CEU 695218 48182592 46344110
NA12763.1.M1202095 NA12763 CEU 542301 22455894 21380847
NA12763.2.M1112168 NA12763 CEU 1069667 63667750 60888371
NA12775.1.M1202094 NA12775 CEU 6236026 28394024 21532330
NA12775.7.M1202195 NA12775 CEU 3099117 97212116 91357813
NA12776.1.M1202093 NA12776 CEU 1135993 22743282 21054957
NA12776.6.M1201196 NA12776 CEU 1465831 61771810 58639052
NA12777.1.M1202094 NA12777 CEU 641368 29398350 27952492
NA12777.4.M1202086 NA12777 CEU 490979 51273808 49311640
NA12778.1.M1111244 NA12778 CEU 4645786 59227324 53196257
NA12812.1.M1111244 NA12812 CEU 796171 44647732 42822044
NA12813.1.M1202096 NA12813 CEU 1178566 26241158 24439211
NA12813.2.M1112166 NA12813 CEU 843789 51803402 49591230
NA12814.1.M1202093 NA12814 CEU 766696 35313330 33751016
NA12814.7.M1202193 NA12814 CEU 1476289 89433746 85879138
NA12815.1.M1111243 NA12815 CEU 1723726 74284182 70590711
NA12827.1.M1202098 NA12827 CEU 656752 23489612 22244967
NA12827.3.M1202022 NA12827 CEU 422444 30801584 29575941
NA12829.1.M1202094 NA12829 CEU 653417 26240620 24933843
NA12829.7.M1202194 NA12829 CEU 1640141 82367814 78632478
NA12830.1.M1111242 NA12830 CEU 707555 41184128 39460984
NA12842.1.M1202095 NA12842 CEU 578882 28664450 27439826
NA12842.6.M1201194 NA12842 CEU 958363 65530232 63045175
NA12843.1.M1202095 NA12843 CEU 622558 20469766 19364955
NA12843.6.M1201194 NA12843 CEU 728628 44197168 42283889
NA12872.1.M1202093 NA12872 CEU 1185557 32769378 30832771
NA12872.2.M1112162 NA12872 CEU 1299194 64209084 61267310
143
NA12873.1.M1202097 NA12873 CEU 1090229 23608376 21935062
NA12873.7.M1202191 NA12873 CEU 2193540 69998210 65986258
NA12874.1.M1202093 NA12874 CEU 467501 23604870 22561940
NA12874.3.M1202022 NA12874 CEU 495824 55673256 53690157
NA12889.1.M1202094 NA12889 CEU 741035 27449168 26007988
NA12889.3.M1202237 NA12889 CEU 13057010 81745992 66682723
NA12890.1.M1111243 NA12890 CEU 3812255 56224248 51053484
NA18486.1.M1202096 NA18486 YRI 546872 30091826 28854859
NA18486.7.M1202194 NA18486 YRI 2487061 94159158 89435145
NA18487.1.M1202097 NA18487 YRI 740070 34987964 33451785
NA18487.6.M1201195 NA18487 YRI 761924 44275528 42489000
NA18488.1.M1202098 NA18488 YRI 690450 28457404 27076061
NA18488.4.M1202087 NA18488 YRI 634443 36480658 34908449
NA18489.1.M1202098 NA18489 YRI 576087 27651430 26481968
NA18489.2.M1112161 NA18489 YRI 800135 52162678 50131322
NA18498.1.M1202092 NA18498 YRI 6401837 27781720 20882415
NA18498.2.M1201311 NA18498 YRI 1667741 72699928 69203972
NA18499.1.M1111242 NA18499 YRI 1015040 64316356 61832072
NA18502.1.M1202096 NA18502 YRI 785012 28938892 27501338
NA18502.7.M1202198 NA18502 YRI 3286941 113740072 107761739
NA18505.1.M1202094 NA18505 YRI 752045 32068630 30616719
NA18505.3.M1202021 NA18505 YRI 1369183 31203700 29094659
NA18508.1.M1111241 NA18508 YRI 1073954 51680710 49353199
NA18510.3.M1202027 NA18510 YRI 540956 41294578 39761588
NA18511.1.M1202091 NA18511 YRI 454649 26988772 25928585
NA18511.7.M1202192 NA18511 YRI 2760040 107587174 102297612
NA18517.1.M1202097 NA18517 YRI 787412 25942230 24486268
NA18517.3.M1202021 NA18517 YRI 2603814 30457778 27078338
NA18519.1.M1111243 NA18519 YRI 878229 48033590 46000678
NA18520.1.M1111241 NA18520 YRI 1052477 53217190 51047437
NA18858.1.M1202097 NA18858 YRI 7417591 41246304 32938824
NA18858.2.M1112168 NA18858 YRI 1026927 58240252 55560270
NA18861.1.M1202092 NA18861 YRI 755384 32249850 30771111
NA18861.4.M1202085 NA18861 YRI 722266 50615720 48066771
NA18867.1.M1111242 NA18867 YRI 3635849 56567642 51846383
NA18868.1.M1202097 NA18868 YRI 689232 30762466 29366828
NA18868.5.M1201313 NA18868 YRI 481967 59639732 57708621
NA18870.1.M1202094 NA18870 YRI 781887 31979368 30478087
NA18870.6.M1201194 NA18870 YRI 897463 46007508 44007519
NA18873.1.M1202096 NA18873 YRI 666307 30937178 29526237
NA18873.4.M1202087 NA18873 YRI 685147 52677010 50678941
NA18907.1.M1202091 NA18907 YRI 702851 35090840 33600948
NA18907.6.M1202171 NA18907 YRI 2984775 49814026 45668105
NA18908.1.M1202098 NA18908 YRI 7069507 38656240 30928852
NA18908.7.M1202197 NA18908 YRI 1162491 67258558 64581693
NA18909.1.M1202098 NA18909 YRI 893969 30875610 29286536
NA18909.4.M1202088 NA18909 YRI 991507 56130518 53714052
NA18910.1.M1202095 NA18910 YRI 769182 35553956 34004428
NA18910.3.M1202027 NA18910 YRI 1076429 35873940 33966465
NA18912.1.M1202095 NA18912 YRI 935148 36505036 34721286
NA18912.7.M1202193 NA18912 YRI 1812232 91363368 87325612
NA18916.1.M1202097 NA18916 YRI 765457 36217570 34558999
NA18916.2.M1112156 NA18916 YRI 1316649 82615366 79139060
NA18917.1.M1111245 NA18917 YRI 898028 53942416 51764508
NA18923.1.M1202096 NA18923 YRI 625596 32529660 31095621
NA18923.2.M1112165 NA18923 YRI 739258 62831466 60419340
NA18933.1.M1111242 NA18933 YRI 1277885 46992810 44681519
NA18934.1.M1202093 NA18934 YRI 7120174 41845334 33943370
NA18934.3.M1202237 NA18934 YRI 2001916 97198420 92841927
NA19092.1.M1111243 NA19092 YRI 1169082 69954692 67198906
NA19093.1.M1202097 NA19093 YRI 734898 32406668 30978634
NA19093.7.M1202197 NA19093 YRI 1112907 66525900 63901808
NA19095.1.M1111248 NA19095 YRI 958786 63781962 61378338
NA19095.1.M1202091 NA19095 YRI 1371899 63705330 60914601
NA19095.2.M1201312 NA19095 YRI 1970329 84139054 80132537
NA19095.3.M1202021 NA19095 YRI 599099 38738526 37223429
NA19095.4.M1202082 NA19095 YRI 701006 41379842 39770091
NA19095.5.M1201315 NA19095 YRI 628539 61447466 59308564
NA19095.6.M1201194 NA19095 YRI 835826 53431154 51375555
NA19095.7.M1202198 NA19095 YRI 1181819 49312350 47009267
NA19096.1.M1202098 NA19096 YRI 679613 28342460 27014374
NA19096.4.M1202084 NA19096 YRI 505610 48896484 47197700
NA19098.5.M1201311 NA19098 YRI 788713 79091478 76520463
NA19099.1.M1202094 NA19099 YRI 487662 23438620 22460253
NA19099.2.M1112157 NA19099 YRI 1581226 75752600 72391829
NA19102.1.M1111241 NA19102 YRI 929919 49235462 47210156
NA19107.1.M1202094 NA19107 YRI 775935 37918418 36329958
NA19107.2.M1112165 NA19107 YRI 743966 54005276 52023844
NA19108.1.M1202094 NA19108 YRI 6983460 50855512 42941900
NA19108.5.M1201317 NA19108 YRI 1387580 98151102 94619690
NA19113.1.M1202091 NA19113 YRI 1130215 44703518 42578879
NA19113.3.M1202021 NA19113 YRI 1201208 30804884 28908837
NA19114.1.M1202098 NA19114 YRI 909412 41503732 39622315
NA19114.2.M1112157 NA19114 YRI 1393051 62100390 59256532
NA19116.1.M1202093 NA19116 YRI 715148 34167284 32569306
NA19116.2.M1112157 NA19116 YRI 1609082 77214832 73610780
NA19117.1.M1111244 NA19117 YRI 1067822 66551954 63998574
NA19118.1.M1202095 NA19118 YRI 861450 34496750 32751834
NA19118.7.M1202198 NA19118 YRI 2653966 95610272 90533813
NA19119.1.M1202095 NA19119 YRI 689621 30892858 29496781
NA19119.3.M1202024 NA19119 YRI 313856 32705756 31579620
NA19121.1.M1202096 NA19121 YRI 793864 44170020 42272143
NA19121.3.M1202026 NA19121 YRI 882659 48867404 46626901
NA19129.1.M1202096 NA19129 YRI 6499666 41752726 34373650
NA19129.6.M1202171 NA19129 YRI 931321 47718096 45579140
NA19130.1.M1202091 NA19130 YRI 1015625 36496846 34575684
NA19130.5.M1201317 NA19130 YRI 709294 53927418 51809009
NA19131.1.M1202093 NA19131 YRI 694556 36181184 34674022
NA19131.2.M1112158 NA19131 YRI 1487748 76044278 72764141
NA19137.1.M1111247 NA19137 YRI 3347374 64596650 59692694
NA19138.1.M1202097 NA19138 YRI 567080 25018412 23894997
NA19138.3.M1202028 NA19138 YRI 785540 40445678 38710935
NA19141.1.M1202091 NA19141 YRI 688008 39049606 37324085
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NA19141.6.M1201192 NA19141 YRI 868874 57160634 54729755
NA19143.1.M1202094 NA19143 YRI 462505 32056936 30816605
NA19143.2.M1112168 NA19143 YRI 1186604 66746326 63723187
NA19144.1.M1202091 NA19144 YRI 746849 37208028 35589470
NA19144.4.M1202082 NA19144 YRI 806361 48314536 46064324
NA19146.1.M1202098 NA19146 YRI 749022 35299478 33768452
NA19146.5.M1201315 NA19146 YRI 701961 68335568 66007383
NA19147.2.M1201312 NA19147 YRI 1885058 91607896 87478858
NA19149.1.M1111242 NA19149 YRI 1063932 52899822 50658698
NA19150.1.M1202097 NA19150 YRI 677978 38844354 37276872
NA19150.5.M1201317 NA19150 YRI 505172 59069450 57221045
NA19152.1.M1202093 NA19152 YRI 708818 30190086 28739650
NA19152.4.M1202084 NA19152 YRI 657902 55519748 53420523
NA19153.1.M1111247 NA19153 YRI 6972240 71540736 63046762
NA19159.1.M1202098 NA19159 YRI 661279 29193900 27862994
NA19159.3.M1202236 NA19159 YRI 3133144 166643202 159267717
NA19160.1.M1202095 NA19160 YRI 6627986 35955522 28658699
NA19160.3.M1202023 NA19160 YRI 522494 38940964 37565198
NA19171.1.M1111247 NA19171 YRI 1801954 72147472 68743842
NA19172.1.M1202098 NA19172 YRI 974384 35716758 33919148
NA19172.6.M1201191 NA19172 YRI 966576 51461332 49251422
NA19175.1.M1202092 NA19175 YRI 966273 34478264 32696848
NA19175.4.M1202088 NA19175 YRI 1266429 57601384 54886441
NA19184.1.M1111241 NA19184 YRI 1394492 75131880 72020503
NA19185.1.M1202094 NA19185 YRI 599690 28535644 27243396
NA19185.6.M1201194 NA19185 YRI 924237 58016328 55589600
NA19189.1.M1202098 NA19189 YRI 738061 38548800 36963953
NA19189.5.M1201317 NA19189 YRI 699545 66763910 64591812
NA19190.1.M1202098 NA19190 YRI 758232 37325236 35628714
NA19190.4.M1202082 NA19190 YRI 622506 57409818 55340294
NA19197.1.M1202093 NA19197 YRI 848627 34598466 32865875
NA19197.3.M1202022 NA19197 YRI 664168 40357220 38615016
NA19198.1.M1202093 NA19198 YRI 1092953 34767974 32808474
NA19198.2.M1112156 NA19198 YRI 1640335 65593110 62281164
NA19200.1.M1202096 NA19200 YRI 771182 35994658 34426071
NA19200.2.M1112161 NA19200 YRI 759117 56585102 54528843
NA19201.1.M1111243 NA19201 YRI 1238615 60908980 58326549
NA19204.1.M1111246 NA19204 YRI 1118926 51301070 49161636
NA19206.1.M1202092 NA19206 YRI 717078 26310108 24842610
NA19206.2.M1112155 NA19206 YRI 1579214 75803142 71968105
NA19207.1.M1202098 NA19207 YRI 750381 23631760 22306606
NA19207.4.M1202085 NA19207 YRI 633204 57760084 55696912
NA19209.1.M1202092 NA19209 YRI 744334 35587584 34011763
NA19209.6.M1202171 NA19209 YRI 612491 44884530 43195870
NA19210.1.M1202091 NA19210 YRI 1024271 34978590 33148156
NA19210.4.M1202081 NA19210 YRI 526065 43178400 41582911
NA19213.1.M1202091 NA19213 YRI 6605000 40562894 33208194
NA19213.2.M1112156 NA19213 YRI 1549155 71368052 68172822
NA19214.1.M1202097 NA19214 YRI 1038660 43024104 40996641
NA19214.6.M1201192 NA19214 YRI 852827 57983370 55754520
NA19222.1.M1202091 NA19222 YRI 699576 36104426 34424293
NA19222.2.M1112167 NA19222 YRI 935195 64371830 61574224
NA19223.1.M1202091 NA19223 YRI 852803 37198786 35477678
NA19223.7.M1202196 NA19223 YRI 1869615 92228512 88194023
NA19225.1.M1202092 NA19225 YRI 916024 47618624 45565620
NA19225.6.M1201195 NA19225 YRI 834298 57960778 55734819
NA19235.1.M1111246 NA19235 YRI 855494 70264650 67926401
NA19236.1.M1202095 NA19236 YRI 961511 33356244 31604451
NA19236.4.M1202081 NA19236 YRI 734626 42875714 41150748
NA19247.1.M1202092 NA19247 YRI 887882 35936012 34128994
NA19247.3.M1202237 NA19247 YRI 4190710 65714138 59781856
NA19248.1.M1202092 NA19248 YRI 1068769 33725644 31862989
NA19248.5.M1201311 NA19248 YRI 1058983 60364088 57790440
NA19256.1.M1202093 NA19256 YRI 737365 28249682 26802851
NA19256.6.M1201196 NA19256 YRI 826371 57800698 55566909
NA19257.1.M1202091 NA19257 YRI 713380 29762202 28322271
NA19257.6.M1201192 NA19257 YRI 1175300 63081626 60270689
NA20502.3.M1202024 NA20502 TSI 633546 46292322 44530139
NA20503.1.M1111245 NA20503 TSI 890461 50576464 48520549
NA20504.1.M1111247 NA20504 TSI 873840 52388216 50156206
NA20505.1.M1111246 NA20505 TSI 1386864 75876982 72937909
NA20506.1.M1202092 NA20506 TSI 1235196 48177866 45694986
NA20507.1.M1111247 NA20507 TSI 915012 54090610 51788916
NA20508.1.M1111242 NA20508 TSI 1504226 65015656 62135970
NA20509.7.M1202197 NA20509 TSI 3495647 116113638 109766384
NA20510.3.M1202023 NA20510 TSI 406400 31600254 30466351
NA20512.1.M1202098 NA20512 TSI 712457 39175038 37498931
NA20512.6.M1201196 NA20512 TSI 716226 48923668 46941086
NA20513.1.M1202096 NA20513 TSI 1016314 47900866 45822184
NA20513.4.M1202081 NA20513 TSI 614005 54588288 52677025
NA20514.1.M1111244 NA20514 TSI 874892 52609404 50501234
NA20515.5.M1201311 NA20515 TSI 1185628 72288146 68765179
NA20516.5.M1201313 NA20516 TSI 644602 58987376 56768351
NA20517.3.M1202028 NA20517 TSI 651552 42745682 41096770
NA20518.1.M1202096 NA20518 TSI 2328207 37620722 34448089
NA20518.4.M1202083 NA20518 TSI 671751 60964606 58861539
NA20519.1.M1111245 NA20519 TSI 1217384 73240716 70346932
NA20520.3.M1202022 NA20520 TSI 837383 28492330 26885814
NA20521.7.M1202197 NA20521 TSI 1160805 47577258 45157629
NA20524.2.M1112158 NA20524 TSI 1261407 64680104 61686490
NA20525.1.M1111241 NA20525 TSI 1037883 56474686 54020530
NA20527.1.M1111246 NA20527 TSI 1089908 72760118 69963798
NA20527.1.M1202091 NA20527 TSI 1186425 62452370 59758406
NA20527.2.M1112157 NA20527 TSI 1736132 78156530 74353805
NA20527.3.M1202023 NA20527 TSI 367109 27020918 26023917
NA20527.4.M1202082 NA20527 TSI 966546 53374222 51106626
NA20527.5.M1201311 NA20527 TSI 741658 69314238 66800192
NA20527.6.M1201195 NA20527 TSI 691849 42369242 40655587
NA20527.7.M1202198 NA20527 TSI 1475223 57549132 54662278
NA20528.2.M1201311 NA20528 TSI 1669474 64047602 60748869
NA20529.2.M1112156 NA20529 TSI 1599382 62725976 59236410
NA20530.2.M1112156 NA20530 TSI 1148763 73163546 69900982
NA20531.4.M1202081 NA20531 TSI 598596 56589316 54661981
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NA20532.1.M1202095 NA20532 TSI 1697847 37047316 34448800
NA20532.3.M1202027 NA20532 TSI 2295902 40565342 37266815
NA20534.2.M1112158 NA20534 TSI 1899371 69522208 65790691
NA20535.3.M1202022 NA20535 TSI 633996 51054612 49085769
NA20536.1.M1111241 NA20536 TSI 1164949 48563226 46297925
NA20537.3.M1202028 NA20537 TSI 904841 42493642 40481686
NA20538.1.M1202095 NA20538 TSI 610884 23633388 22427211
NA20538.3.M1202026 NA20538 TSI 614099 30945634 29451080
NA20539.4.M1202085 NA20539 TSI 736229 54419362 52261367
NA20540.1.M1111242 NA20540 TSI 1003907 43122492 41077962
NA20541.1.M1111244 NA20541 TSI 1286550 70862334 67783961
NA20542.7.M1202192 NA20542 TSI 1485413 40504508 37927522
NA20543.1.M1202098 NA20543 TSI 1138898 38104108 35996270
NA20543.2.M1112155 NA20543 TSI 744267 53774994 51554174
NA20544.4.M1202085 NA20544 TSI 583495 53373484 51281171
NA20581.1.M1111244 NA20581 TSI 759189 46565118 44789200
NA20582.4.M1202082 NA20582 TSI 630883 63922312 61608501
NA20585.3.M1202026 NA20585 TSI 505441 38528754 37087075
NA20586.2.M1112157 NA20586 TSI 1536637 63740492 60150210
NA20588.5.M1201315 NA20588 TSI 823315 61972428 59450006
NA20589.1.M1111243 NA20589 TSI 1248011 60526676 57879685
NA20752.5.M1201317 NA20752 TSI 679320 70510870 68136769
NA20754.1.M1202098 NA20754 TSI 655555 29684412 28376610
NA20754.4.M1202081 NA20754 TSI 529139 49148590 47431969
NA20756.1.M1202094 NA20756 TSI 742828 33035010 31539850
NA20756.2.M1112166 NA20756 TSI 747127 56013648 53752911
NA20757.1.M1111241 NA20757 TSI 1418589 60807078 57864551
NA20758.2.M1112158 NA20758 TSI 1912519 82746652 78492271
NA20759.4.M1202083 NA20759 TSI 637270 46341942 44631092
NA20760.3.M1202025 NA20760 TSI 811560 37635188 35807344
NA20761.1.M1111247 NA20761 TSI 1528755 58661614 55688979
NA20765.1.M1202097 NA20765 TSI 979334 38602064 36656920
NA20765.2.M1112155 NA20765 TSI 1449420 86041348 82389654
NA20766.1.M1111244 NA20766 TSI 1158508 58778104 56234749
NA20768.5.M1201311 NA20768 TSI 1671637 60039132 56819741
NA20769.6.M1201195 NA20769 TSI 782315 42844788 41047256
NA20770.3.M1202021 NA20770 TSI 535786 33257732 31881288
NA20771.1.M1202094 NA20771 TSI 1018433 31960800 30205387
NA20771.2.M1112157 NA20771 TSI 1463564 58780634 55747308
NA20772.3.M1202236 NA20772 TSI 8341509 79218158 68688634
NA20773.1.M1202097 NA20773 TSI 973379 33648318 31854306
NA20773.6.M1201194 NA20773 TSI 848575 48591958 46518112
NA20774.7.M1202191 NA20774 TSI 1393495 42082872 39627515
NA20778.4.M1202081 NA20778 TSI 268583 17279354 16593404
NA20783.4.M1202086 NA20783 TSI 604998 60799330 58712555
NA20785.4.M1202081 NA20785 TSI 733696 54310656 52204325
NA20786.1.M1202098 NA20786 TSI 694653 32119758 30719998
NA20786.2.M1112158 NA20786 TSI 1403649 65654308 62684411
NA20787.6.M1201193 NA20787 TSI 959170 65645640 63047408
NA20790.2.M1112156 NA20790 TSI 928292 54023024 51730387
NA20792.6.M1201196 NA20792 TSI 949584 52821590 50631144
NA20795.5.M1201311 NA20795 TSI 769118 72875624 70416161
NA20796.1.M1202092 NA20796 TSI 2289332 103677232 99030240
NA20797.2.M1112156 NA20797 TSI 1039820 79094216 75634812
NA20798.1.M1202097 NA20798 TSI 830705 39045770 37297027
NA20798.6.M1201196 NA20798 TSI 550778 40597892 39092754
NA20799.1.M1111243 NA20799 TSI 1582489 64787760 61613844
NA20800.1.M1111245 NA20800 TSI 1464204 73763766 70555905
NA20801.7.M1202195 NA20801 TSI 1654123 76258848 72839213
NA20802.1.M1111247 NA20802 TSI 927102 57581676 55162916
NA20803.7.M1202191 NA20803 TSI 3096589 112168988 106102448
NA20804.4.M1202081 NA20804 TSI 774218 54276740 52172136
NA20805.4.M1202087 NA20805 TSI 389860 34905740 33669593
NA20806.3.M1202025 NA20806 TSI 653451 35963954 34295353
NA20807.5.M1201311 NA20807 TSI 982007 67671066 65092361
NA20808.4.M1202086 NA20808 TSI 596061 54180286 52187916
NA20809.6.M1201192 NA20809 TSI 742592 50484026 48464472
NA20810.2.M1112157 NA20810 TSI 1456100 71188628 67774556
NA20811.1.M1111245 NA20811 TSI 880562 48797942 46708256
NA20812.2.M1112166 NA20812 TSI 666723 60337382 58268267
NA20813.5.M1201311 NA20813 TSI 898268 68032742 65399777
NA20814.2.M1112156 NA20814 TSI 953715 65684348 63051875
NA20815.5.M1201315 NA20815 TSI 665495 62647002 60471181
NA20816.3.M1202027 NA20816 TSI 1272231 53197162 50608890
NA20819.3.M1202022 NA20819 TSI 1160829 42423376 40233352
NA20826.1.M1111241 NA20826 TSI 1005035 57621730 55265703
NA20828.2.M1112168 NA20828 TSI 1198492 89680648 85978900
Table 2: Sequence statistics for GEUVADIS samples analysed in Chapter 4.
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Sample name Total reads Unique mapping reads Multi mapping Reads Unmapped reads Patient Region
D10 64701312 48700677 905818 15043055 038/09 HYPO
D11 72201033 53594826 902512 17660372 008/10 SPCO
D12 51161381 40161684 793001 10181114 038/09 CRBL
B12 39674488 32699713 499898 6462974 034/09 OCTX
B10 122871958 103175583 1720207 17951593 031/09 FCTXCON
B11 38772376 32355547 562199 5842997 038/09 FCTXCON
C12 60764815 49316723 923625 10506236 008/10 HIPP
C11 74422308 61219790 1056796 12130836 008/10 FCTXCON
C10 58431937 49117886 987499 8297335 008/10 CRBL
A11 45950648 38097682 574383 7273987 038/09 MEDU
A10 80957108 65421438 906719 14612757 034/09 THAL
A12 77120514 62606433 1133671 13372697 038/09 THAL
C8 67743931 54154498 975512 12600371 008/10 PUTM
C9 65525365 53999453 937012 10569241 008/10 TCTX
A1 64270292 53781380 951200 9518430 034/09 CRBL
A3 67397213 54679358 768328 11936046 034/09 FCTXCON
A2 62170292 49817054 789562 11545023 031/09 PUTM
A5 58341045 47343758 700092 10291360 034/09 PUTM
A4 59525146 49149913 714301 9649026 031/09 OCTX
A7 64145906 51983842 718434 11430800 034/09 TCTX
A6 60778108 49242423 784037 10739491 031/09 HIPP
C3 63805190 52065035 1001741 10719271 038/09 WHMT
A8 62254243 51272594 977391 9985580 038/09 PUTM
C1 60503694 49207654 792598 10491340 031/09 TCTX
C7 67246545 56991446 988524 9253124 008/10 THAL
C6 66879537 53122416 936313 12807431 008/10 SNIG
C5 66601578 55685579 959062 9936955 038/09 OCTX
C4 70032920 58547521 1085510 10385882 038/09 HIPP
D8 76677023 60774208 835779 15044031 034/09 HYPO
B3 72673896 56540291 1010167 15123437 038/09 SNIG
A9 59717189 48836717 758408 10116091 034/09 HIPP
C2 59945948 49437423 1438702 9051838 038/09 TCTX
B8 65649228 54849929 833745 9952422 031/09 THAL
D3 73385630 59779934 1042075 12534265 008/10 MEDU
B4 60320675 45759264 621302 13934075 034/09 MEDU
B5 65012072 52607768 864660 11533141 031/09 WHMT
B6 58277446 49611589 967405 7675139 031/09 CRBL
B7 60177454 48075768 728147 11361503 031/09 SNIG
B1 71112243 57259578 760901 13084652 034/09 SNIG
B2 79439930 63218296 929447 15276298 031/09 MEDU
D9 65775337 51140324 934009 13654959 038/09 SPCO
D6 68629712 55466533 967678 12161184 031/09 HYPO
D7 70023053 56935744 945311 12113988 034/09 SPCO
D4 68447238 54874150 965106 12580602 031/09 SPCO
D5 70482205 57548720 1134763 11770528 008/10 HYPO
D2 67810799 53278944 901883 13609627 008/10 WHMT
B9 67515639 54005759 884454 12611921 034/09 WHMT
D1 66632426 52579647 892874 13126587 008/10 OCTX
Table 1: Read statistics from UKBEC post mortem brain data.
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